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RESUMEN 
Malaria es un prioridad en los programas de salud publica global. Cada año se registran cerca de 
800 mil a un millón de muertes. Las áreas endémicas mas afectadas por esta enfermedad 
parasitaria son las regiones con altos índices de pobreza y miseria donde la estructura poblacional 
es piramidal y de base amplia. Los niños y las mujeres embarazadas son los grupos que sufren el 
impacto de esta enfermedad transmitida por vectores del genero Anopheles spp. Alrededor de 90 
países en el mundo reportan casos autóctonos y transmisión activa. Enormes esfuerzos se han 
realizado a través del tiempo con el propósito fundamental de aliviar su carga y efecto devastador 
en la salud de las poblaciones afectadas como la carga que conlleva sufrir de esta patología. 
En esta investigación se presenta una combinación de abordajes metodológicos, ontológicos y 
axiológicos, que permiten dar cuenta de los diferente componentes intrínsecos y extrínsecos, que 
afectan las dinámicas de transmisión y control de la malaria. Las limitaciones son inherentes a la 
capacidad del investigador,  y es bastante probable que ese documento no se presente la totalidad 
de factores y determinantes que interactúan en el sistema complejo que abarca la problemática de 
la malaria. Sin embargo, se hace un gran esfuerzo por combinar paradigmas desde el positivista 
hasta el constructivismo histórico, para contribuir en la comprensión de este fenómeno y comparar 
evidencias cualitativas y cuantitativas en áreas endémicas de Colombia y las Américas. El 
propósito es reconstruir las trayectorias y experiencias para el desarrollo y estructuración de 
modelos mejorados de control acordes a los contextos específicos donde la malaria y otras 
patologías de la pobreza mantienen su presencia contribuyendo como determinantes  para que en 
ocasiones las enfermedades resurjan desafiantes tanto para los sistemas de atención en salud 
como para las políticas de control que se implementan. Los capítulos I y II dan cuenta de este 
ejercicio académico, en donde el establecimiento de paradigmas, preguntas ontológicas, 
epistemológicas, axiológicas y metodológicas son delimitadas en termino de variables como 
tiempo, poblaciones y lugares. 
El proceso de análisis inicia con una revisión narrativa de textos indexados y grises que dan cuenta 
de las transformaciones históricas de los conceptos de control, eliminación y erradicación. Esta 
lectura  ha permitido comprender e interpretar que en el tiempo y según las estructuras políticas, 
económicas, sociales y culturales en la línea del tiempo analizada, siglo XX y pare del Siglo XXI, la 
malaria requiere un abordaje tras-disciplinar y de multinivel, y adicionalmente sacar la problemática 
del modelo biologicista a un contexto bio-socio-político mas incluyente y amplio. La malaria es un 
fenómeno complejo y como tal  las estrategias de control, eliminación y erradicación obligan a  
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reconocer los logros parciales de cada intervención implementada a través del tiempo. La  
búsqueda de “balas mágicas” es un proceso constante de reconocimiento de todas las partes y 
actores involucrados, desde los investigadores, la academia, las instituciones hasta la participación 
activa permanente de las comunidades afectadas, y de acercamiento entre lo público y lo privado. 
Esta detallada descripción aparece en el capitulo III, el cual se titulo: Concepts evolution of 
malaria control, elimination and eradication. Historical Review, el cual fue sometido al Journal 
of Malaria. 
Posteriormente y con el propósito de correlacionar y triangular las evidencias primarias y 
secundarias, se realiza la presentación del estudio de campo y revisión narrativa de la situación de 
eliminación de malaria en Colombia y Latin América, el cual aparece en el capitulo IV, con el titulo 
de: Proportion of Fever Attributable to Malaria in Colombia: Potential indicators for tracking 
progress towards malaria elimination. El studio descriptivo y de corte transversal, permitió 
identificar en diferentes escenarios epidemiológicos y socio-demográficos, características comunes 
relacionadas con las dinámicas de transmisión de la malaria. Las regiones endémicas 
seleccionadas para Colombia, comparten problemas estructurales a los de otras regiones 
maláricas en América Latina. Los problemas del sector productivo primario: agricultores, mineros, 
pescadores, y migrantes o desplazados, muestran la injusticia social de las políticas de estado y la 
inequidad entre regiones. La débil gobernanza y pobre inversión como la ausencia de modelos de 
desarrollo, para áreas rurales y peri-urbanas están causalmente relacionadas con las pobres 
condiciones de vida y la presencia de enfermedades de la pobreza. Los sistemas de información y 
alerta temprana de brotes y epidemias es casi inexistente. Los registros semanales de casos y la 
vigilancia de falla terapéutica, o de resistencia a los insecticidas esta pobremente documentada. La 
proporción de asintomáticos aunque baja sigue siendo el problema que se evidencia en los años 
sesenta durante la primera era de erradicación.  
Desde el Desarrollo de las Metas del Milenio, se han retomado los conceptos de eliminación para 
aquellas regiones con programas de control de eventos de baja frecuencia pero de interés en salud 
pública. En el caso de Colombia, el Bocio Endémico y la política de yodación de la sal como 
estrategia costo efectiva de eliminación de este problema, se impulso desde finales del Siglo XIX. 
Sin embargo en 1998, se declaro al país libre de Bocio. Desafortunadamente, la ausencia de 
programas de monitoreo y evaluación, no ha permitido su eliminación y por el contrario la ausencia 
de políticas de control y seguimiento oportunas a la yodación de sal, como de las poblaciones 
afectadas, nos permite decir que hoy esta enfermedad sigue estando presente en niños en edad 
escolar y en mujeres embarazadas, con las consecuencias en el desarrollo cognitivo y de  
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aprendizaje de los escolares pobres de regiones deprimidas. En el capitulo V,  se revisa la política 
y el retroceso de control que ha tenido el Bocio Endémico en Colombia, y nos ejemplifica, las 
debilidades de acompañamiento y sistemas de vigilancia en programas de control hasta alcanzar la 
meta del Zero. El capitulo aborda nuevamente desde el constructivismo la transformación en el 
tiempo de la política de control y su retroceso : Historical Review of the current sanitary policy 
of  goiter elimination in Colombia,  1990-2012 
Finalmente, en el capitulo VI, hay una reflexión y triangulación de fuentes, con el propósito de 
cuestionar los logros y desafíos a los que los programas de control y de salud pública se enfrentan 
en la búsqueda de reducir la carga de enfermedad, y sus efectos en bucle causal para los mas 
pobres y desprotegidos. No menos importante, se plantean nuevas preguntas de investigación que 
en consulta de fuentes aparentemente están sin respuesta, y requieren adicionales investigaciones 
operativas, y el desarrollo de intervenciones novedosas, que impacten en la incidencia de la 
enfermedad desde la prevención primaria, pero apoyada en programas de promoción de la salud, 
atención primaria en salud, y el fortalecimiento de los sistemas de información.  
En conclusiones, los resultados confirman la necesidad de definir mecanismos de vigilancia, 
evaluación y monitoreo de los programas de eliminación. El acompañamiento permanente a los 
servicios de salud de las áreas endémicas, como el desarrollo de políticas y modelos de desarrollo, 
para las áreas mas vulnerables, con necesidades particulares, requieren dada su complejidad 
abordajes integrales, donde las estructuras primarias de la sociedad, puedan disminuir las brechas 
de equidad, y reducir al máximo las injusticias sociales con apoyo participativo y activo de la 
comunidad. 
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SUMMARY 
Malaria is a priority disease on the global public health agenda, with between 800 thousand and 
one million deaths reported annually. The endemic areas most affected by this parasitic disease 
have high poverty rates across broad population groups. Children and pregnant women suffer the 
biggest impacts from this disease, which is transmitted by Anopheles spp. mosquitoes. About 90 
countries worldwide report indigenous cases with active transmission. Enormous efforts are on-
going to alleviate the disease burden and its devastating effect on health in vulnerable populations.  
This research presents a combination of methodological, ontological, and axiological approaches in 
order to further understand the intrinsic and extrinsic components of malaria which affect the 
dynamics of transmission and control measures. Limitations are inherent in the ability of the 
researcher, and this document is unlikely to fully present all factors and determinants which interact 
in the complex system of malaria. Nonetheless, it reflects a major effort to combine paradigms from 
positivism to historical constructivism. The purpose of this work is to contribute to the understanding 
of this phenomenon and compare qualitative and quantitative evidence in malaria-endemic areas of 
Colombia and the Americas. Additional effort is made to reconstruct the trajectories and 
experiences of control and prevention and recognize elements to improve models of control, 
considering the specific contexts where malaria and other diseases of poverty persist. In Chapters I 
and II, the realities and nature of the problem are defined, specifically to establish  paradigms as 
well as ontological, epistemological, axiological and methodological questions, while the objective of 
the research  is defined in terms of variables such as time, people and places. 
The analysis process begins with a narrative review of gray literature and indexed texts covering the 
historical transformations of concepts of control, elimination and eradication of malaria. The 
compilation of sources interprets the effect of political, economic, social and cultural structures on 
trends of malaria and diseases of poverty. Additionally, the problem of elimination of infectious 
diseases is followed from a “biologist model” to a more inclusive and broad bio-socio-political 
context. Malaria is a complex phenomenon, and control/ elimination /eradication strategies should 
not underestimate the importance of partial achievements from interventions implemented over 
time. The search for "magic bullets" is a constant and continual process of recognition by all 
involved actors, including researchers, academic and public-private institutions, as well as 
sustained active participation by the affected communities. The detailed description of this process 
is presented in Chapter III, Concepts evolution of malaria control, elimination and eradication. 
Historical Review, as submitted to the Journal of Malaria. 
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In order to correlate and triangulate the primary and secondary evidence, field work to identify 
epidemiological markers of advancement and a narrative review on the status of elimination of 
malaria in Colombia and Latin America are analyzed. These findings are reported in Chapter IV, 
Proportion of fever attributable to malaria in Colombia: Potential indicators for tracking 
progress towards malaria elimination. A cross-sectional survey descriptive study, conducted in 
two regions of Colombia, aimed to identify risk factors (epidemiological and socio-demographic) and 
baseline characteristics related to the dynamics of malaria transmission. These two regions shared 
similar structural problems with other malaria endemic regions of Latin America. The field results 
are strongly correlated with the narrative review. Part of the problem is explained through the 
primary productive sector, which consists of farmers, miners, fishermen, and migrants/displaced 
persons, reflecting social injustice and inequalities between regions under the same public policies. 
Poor governance and reduced infrastructure investment for the health and education sectors, 
combined with scarce development models for rural and peri-urban areas, produce inadequate 
living conditions which perpetuate diseases of poverty and high rates of maternal and infant 
mortality. Information systems for early prediction of outbreaks and epidemics are inadequate or 
non-existent. Recording of cases on a weekly basis and monitoring of therapeutic failures and 
insecticide resistance are poorly documented. The proportion of asymptomatic individuals, despite 
the low reported rates, remains a clinical and epidemiological problem. 
In the objectives of the Millennium Development Goals, the concepts of elimination particularly 
focused interest on public health programs. In the case of Colombia, other diseases of poverty can 
be used as epidemiological markers of the goals achieved. Using the example of endemic goiter, 
the policy of salt iodization has been adapted as the most cost effective strategy for elimination. By 
1998, Colombia declared the country free of goiter. Unfortunately, the lack of monitoring and 
evaluation programs has hindered appropriate follow up to ensure continued iodization of salt. This 
study indicates that the disease is still prevalent in school children and pregnant women. In Chapter 
V, entitled Historical review of the current sanitary policy of goiter elimination in Colombia, 
1990-2012, a review on the control policy addresses the decline from a constructivism paradigm. 
In Chapter VI, the impact of this research to improve the policy of elimination, considering local 
examples which are widely generalizable to other endemic areas in the same region of the 
Americas, is presented. New research questions for additional operational research and the 
development of novel interventions which impact on the incidence of disease are articulated. 
In conclusion, these results confirm the need to define mechanisms for monitoring and evaluation of 
programs for elimination. Given the complexity of the health problems, strategies of control must 
consider reducing inequities, social injustice, and, importantly, the gender component, which are 
consequences of violence in Colombia. 
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Chapter I Introduction
Public health researchers consider a wide range of diseases and try to study their determinants, 
thereby offering a foundation for action and for planning and intervention strategies. Health systems 
and control programs design models that characterize populations in terms of the distribution and 
magnitude of a specific health problem. Interventions are selected and implemented based on a 
cost benefit analysis and on the effectiveness demonstrated by predictive models. Supply and 
demand relationships determine the quality and coverage of public health programs and establish 
indicators for monitoring and evaluation.  The most important goal of a health system, according to 
the WHO, is to promote universal health care, ensuring that all people receive health care without 
suffering financial hardship as a result; unfortunately, many health systems have not yet arrived at 
this point(1). As Kenneth Arrow suggested, the health care economy is affected by markets and 
“the special economic problems of medical care can be explained as adaptations to the existence of 
uncertainty in the incidence of disease and in the efficacy of treatment” (2). This assumption is 
commonly observed in low-, middle-, and high-income countries. On one side, there are 
transmissible diseases,classified as either diseases of povertylike most  vector borne pathologies 
i.e. dengue, chikungunya, leishmaniasis, zika yellow fever, or as chronic infectious diseases, like 
HIV or TB. On the other side, the study and control of chronic diseases with long periods of latency, 
like cancer, cardiovascular diseases and obesity related to diabetes, represent high coststo health 
systems and public policies. In addition,implementing health promotion and disease prevention 
strategies (from basic to primary and secondary prevention) requires substantial economic 
investmentsin both qualified human resources and in physical infrastructure.  Long-term variations 
in the patterns of disease transmission and presentation, in terms of time and location,cannot be 
forecasted.  
In addition to this epidemiological transition, demographic changes are also evident in all regions of 
the world. Permanent migration between continents, political unrest and resulting flows of refugees 
present a challengefor control and elimination programs to achieve their stated goals. Related 
programs and reforms are designed in consideration of the principles of universality and solidarity in 
providing medical care; unfortunately, program coverage and access does not always extend to 
various segments of the population. 
The purpose of this study is to look at health policies designed to eliminate and eradicate diseases 
prevalent in endemic regions, but under conditions of widespread poverty.The factors and 
determinants of policy/program success or failure are also discussed and correlated with the socio-
economic structure of the countries.  
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1.1 From outbreaks and epidemics to elimination and eradication 
Those who study the history of communicable disease epidemiology consider several important 
outbreaks and epidemicsfrom which to glean lessons for today. From the plague of Athens in 500 
BC and the Black Death in Europe in 1330, through to the cholera epidemic in Londonin 1840, 
(studied extensively by Sir John Snow) and the most recent Ebola epidemic in 2014,each success 
and failure along the wayhas contributed to ourunderstanding of the natural history of disease and 
to the development of palliative or curative procedures. 
In the 20th century, considerable advancesin science and technology led to several innovations with 
enormous utility in the field of disease control. Public health and epidemiological evidencehas been 
being consolidated throughscientific publications and science and technology networks, reflecting 
the needs of and considering the differences between particular regions, health systems and 
epidemiological profiles.In a similar way, international policy has evolved to meet specific health 
priorities. Since the mid-1950s, considerable efforts to reduce social injustice between regions have 
been implemented. Health for all by the year 2000 was the proposal of the 1970s, unfortunately with 
limited results but enough evidence to support new international policies of health. The Millennium 
Development Goals (MDGs)was another global strategy for reducing inequities between regionsand 
was implemented between 2000 and 2015. In this strategy, efforts focused on decreasing the 
burden of disease caused by malaria, HIV, and TB. Other diseases of poverty were neglected and 
new alliances were created to alleviate hunger, malnutrition, and diseases of poverty, suffering and 
discrimination among vulnerable populations around the world. Table 1 shows the MDGs. The focus 
here on reducing poverty and empowering women, from an equity perspective, 
contributedsubstantially to reducing infant and maternal mortality, a health priority in all regions. 
It is important to mention that throughout the history of public health, several victories have been 
won, mainly in the field of elimination and eradication.  The most celebratedof these was smallpox 
eradication in 1977. To achieve this goal,eradication effortswere supported by health sectors, 
strong political interventions and the widespread use of an inexpensive vaccine that was simple and 
easy to administer. Smallpox eradication was possible because of anexisting, well-known and 
highly efficaciousvaccine and because of well-organized health services with strategic plans and 
periodic evaluation of the state of immunization. Successful eradication has been attributed to the 
implementation of an efficient surveillance system, including permanent monitoring to detect and 
forecast epidemics and outbreaks, which was essential to eventually declaring the world free of 
smallpox (3)(4)(5).  
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Other important successeson the way to elimination and eradication include the global reduction of 
measles incidence by 91%,between 2000 and 2006; concerted efforts to eliminate Rubella in 
Europeand the reduction of American Trypanosomiasis incidence in Latin America by  
Table 1. UN Millennium development goals 
The goals Action 
1. Eradicate extreme poverty and hunger
• Reduce by half the proportion of people living on less than a dollar a
day 
• Reduce by half the proportion of people who suffer from hunger
2. Achieve universal primary education 
• Ensure that all boys and girls complete a full course of primary 
schooling 
3. Promote gender-equality and 
empower women 
• Eliminate gender-disparity in primary and secondary education, 
preferably by 2005, and at all levels by 2015 
4. Reduce child mortality • Reduce the mortality rate among children under five by two-thirds
5. Improve maternal health • Reduce the maternal mortality ratio by three-quarters
6. Combat HIV/AIDS, malaria and other
diseases 
• Halt and begin to reverse the spread of HIV/AIDS
• Halt and begin to reverse the incidence of malaria and other major 
diseases
7. Ensure environmental sustainability
• Integrate the principles of sustainable development into countries’
policies and programs; reverse loss of environmental resources
• Reduce the proportion of people without sustainable access to safe 
drinking water by half
• Achieve significant improvement in the lives of at least 100 million 
slum dwellers, by 2020 
8. Develop a global partnership for
development 
• Develop further an open trading and financial system that is rule-
based, predictable and non-discriminatory, including a commitment
to good governance, development and poverty reduction 
(nationally and internationally)
• Address the least-developed countries’ special needs. This includes
tariff- and quota-free access for their exports, enhanced debt relief 
for heavily-indebted poor countries, cancellation of official bilateral 
debt and more generous official development-assistance for 
countries committed to poverty-reduction
• Address the special needs of landlocked and small island developing 
states 
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• Deal comprehensively with developing countries’ debt problems
through national and international measures to make debt 
sustainable in the long-term
• In cooperation with the developing countries, develop decent and
productive work for youth
• In cooperation with pharmaceutical companies, provide access to
affordable essential drugs in developing countries
• In cooperation with the private sector, make available the benefits
of new technologies, especially information and communications 
technologieshttp://www.un.org/millenniumgoals/index.h
tml
Source: United Nations www.un.org/millenniumgoals/index.html# 
more than 70%, between 1983 and 2000(6), (7). Most recently, Colombia was declared free of the 
neglected tropical disease, onchocerciasis, more commonly known as “river blindness”(8). The list 
could be extended to malaria advances in Mesoamerica that reduced transmission considerably, 
and to reductions in the number of leprosy and tuberculosis cases. 
1.2 From elimination to reintroduction: Iodine Disorder Deficiency 
Currently, global elimination policiesmainly focus on infectious diseases, however other diseases of 
poverty such as endemic goiter, associated with iodine deficiency disorder, are also targets of 
elimination.  Iodine deficiency disorders were first treated by consumption of algae rich in iodine. 
Later,this was replaced with iodized salt, introduced in the early 1900s. Over time, the consumption 
of iodized salt contributed to eliminating this condition in many countries. Unfortunately, in New 
Zealand, Australia, and some European countries, iodine deficiency disorder continuesto be an 
important public health problem. It is even more common in developing countries like Colombia. 
Primary prevention strategies have strongly recommended low consumption of salt to prevent 
cardiovascular diseases. However, there is a trend towards consuming more processed foods, rich 
in iodized salts. In Colombia, the first reported cases of goiter occurred around 1820-1823. By 
1990, the country was declared free of endemic goiter. By 2013, a study conducted by Valero, 
Franco and Cuellar showed a frequency of this pathology of 15 to 30% among children between the 
ages of 6 and 14 years old in Bogota. Iodine in urine was also measured and almost 80% of 
children excreted more than 200 mg/ml, suggesting over consumption of iodized salt. Both 
disorders, related to iodine consumption, are associated with thyroid diseases. These findings 
suggest that the elimination policy for goiter disease has not been controlled, monitored or 
evaluated sufficiently.The population is further affected by the absence of control and supervision of 
the iodized salt industry(9).  
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1.3 Malaria case study: A disease of the poor and neglected 
Malaria is one of the major diseases of poverty and several agencies providefinancing to decrease 
the socio-economic impact and burden of the disease. The eradication and global control strategy 
popular from 1948 to1990changed approach to meet the objectives of the MDGs, whichpromoted a 
new era of elimination and eradication. This new global approach to eliminating and eradicating 
malaria has faced a considerable number of challenges. The number of agencies financing basic 
and applied research in this area isinsufficient. The WHO malaria program recognizes that funding 
remains scarce, starting from USD 100 million in 2000 to USD 1.94 billion in 2012 and USD 1.97 
billion in 2013(10). Given the limited number of indicators reached, the global community is 
transitioning to a new set of 17 goals, called the Sustainable Development Goals (SDGs), which will 
employ a multidisciplinary approach to reduce poverty and hunger and to improve education and 
nutrition conditions(11). Table 2 shows the goals for malaria 2016-2030.  
Table 2. Objectives, activities and indicators suggested by the Global Technical Strategy for Malaria 
2016–2030 Source: (11) modified  by author 
Planning Objectives 
Indicators of monitoring and 
evaluation 
By year 
Final Indicator 
2020 2025 2030 
1. Reduce malaria mortality rates
globally compared with 2015 
≥40% ≥75% ≥90% 
2. Reduce malaria case incidence
globally compared with 2015 
≥40% ≥75% ≥90% 
3. Eliminate malaria from countries in
which malaria was transmitted in 2015 
At least 10 
countries 
At least 20 
countries 
At least 35 countries 
4. Prevent re-establishment of malaria in
all countries that are malaria-free 
Re-establishment 
prevented 
Re-establishment 
prevented 
Re-establishment prevented 
According to World Health Organization, 3.2 billion people lived in malaria endemic areas in 2015 
(12). The Malaria Report 2010-2015estimated 207 million cases of malaria and about627,000 
related deaths in 2012. By 2013, more than 198 million malaria cases were recorded and estimated 
584000 malaria (93 countries).Of all malaria deaths globally, 90% occur in sub-Saharan Africa. The 
main causes of death in the world are presented in Table 3.Respiratory infections account for 3.9 
million deaths annually, followed by malaria, with uncertainty ranging from 1.3 to 3.0 million deaths 
per year(13). Some differences in the figures can be observed due to methodological variations 
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insources and procedures from surveillance to meta-analysis and systematic reviews. Internal and 
external validity is considerable and has also affected the figures estimated. 
The total number of malaria cases around the world has fallen from 500 million atthe end of the 
20thcentury to fewer than 200 million clinical cases in the currentera of malaria elimination. 
According to the WHO Health Report 2015, malaria has been reduced globally by 30%(10). 
Table 3. Annualglobal deathsfrominfectious diseases, in millions per year: 1990-2010, 2010, 2013. 
Source: (13)(14)(15) 
Infectious Disease 
Deaths in 
Millions 
1990-2010 
(15) 
Deaths in 
Millions 
2010 
(14) 
Deaths in 
Millions 
2013 
(13) 
Respiratory Infections 3.4-2.8 3-4 3.9 
Malaria 1.9-1.7 2 1.3 - 3.0 
HIV/AIDS 0.30-1.15 1 2.5 
Diarrhea 2.5-1.4 5-6 1.8 
Tuberculosis ND-1.2 1 1.7 
Neglected Tropical Diseases ND ND 0.5 
In the Americas,malaria incidence has fallen by 50%. Unfortunately, the crude analyses do not 
show the differences between regions. The serial reporting of cases since 1959 showsan irregular 
trend of malaria patterns. Earlier reports consolidated all of the cases by country. However,the 
Malaria Americas Report 2012, classifies countries by relative level of risk. Haiti, Guyana, 
Suriname, Venezuela, Colombia, Peru and Brazil account forthe highest number of cases(16, 17); 
mainly in poorareas, with high rates of migration. Most health indicators, like access to and 
coverage of health services and public services, are considerably low,correspondingto high rates of 
infant and maternal mortality in the same regions(18). 
In Latin America, slight reductionsin malaria incidence started in themid-nineties (19)(20). The latest 
reportfromthe Pan-American Health Organization (PAHO) 2013 for malaria in the Americas 
gives2012statistics. In this report, the highestAnnual Parasite Incidence (21)arein Mexico, Haiti, 
Guyana, Suriname, Venezuela and Brazil(19). The malaria problems in the Amazon region,eight 
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countries, are explained by non-program related processes of colonization, illegal economies, and 
intensemineralextraction from the soil.  Regional demographic indicators show the presence of 
indigenous populations with high levels of unsatisfied basic needs (UBN), limited presence of health 
services (most of them of very basic level), and geographical barriers toaccess (22), (23), (24, 25), 
(18) 
In Central America, the malaria situation must be analyzed for both continental countries and the 
Caribbean islands. The countrywiththe highestprevalence rates,includingmortality,is Haiti. In 
Mesoamerica, Mexico faces the greatest challenges to reducing the malaria burden. In South 
America, Guyana, Suriname and Brazil are affectedby socio-economic and political conditions that 
undermineliving conditions. Figure 1 shows the distribution of confirmed malaria cases. The 
Pf/Pvratio is around 1:4;  there was a 15% reduction of cases between 2000 and 2004(16). By 
2005, the number of cases had returned to2000 levels. Between 2005 and 2008,cases fell again by 
almost 50%.There was no further reduction from 2008 to 2012 (assuming similar denominators). 
The incidence of Plasmodium vivax has increased considerably during the last decade, 
whilePlasmodium falciparummalaria cases have fallen, as have the number of deaths attributed to 
this species. In Latin America, a malaria case is defined as any individual presenting with symptoms 
compatible with malaria and a positive blood smear. Trend differences between Pv vs. Pf cases 
have beenobserved since 2011 onwards. 
Figure 1. Annual distribution of positive blood smear cases of malaria by passive case 
detection,showing the relation betweenPlasmodium falciparum and Plasmodium vivax in Latin 
America from1959-2012.Source: adapted by the author from PAHO Malaria Report 2012-2014 (16, 
17) and WHO Malaria Report 2015 (10)
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In the Andean region, Venezuela and Peru showed the most positive cases of malaria. Countries 
located in the Southern Cone, Argentina, Chile and Bolivia (southern part bordering Argentina) 
showed a considerable reduction and are considered to bein pre-elimination phase. However, 
additional analyses must be carried out to comparethese figures to seasonal variations, treatment 
failure, treatment,and coverage of the malaria control program. 
1.3.1 Transformation of malaria control policy in Colombia 
Depending on the period of analyses and the structure of comparison, the malaria situation in 
Colombia varies. Analyses conducted between1960 and2014 suggest patterns similar to the rest of 
Latin America, that is, reduction of P. falciparumand increase of P. vivaxmortality and morbidity 
rates (20, 26, 27). Of the several analyses conducted for Colombia, most suggest that the health 
sector reform implemented in1993, introducing the General Social Security System, known as Law 
100, could not have supportedreductiontrends in endemic regions. In fact, the period 1993-2006 
showed an increase eight times the incident rates during the period 1960-1975 (28) , (29). As other 
authors mention, there are seasonal variations. However, it is not possible to asses if peaks occur 
every five, ten or thirty years, given that different variables have been included into the analyses, 
Some authors have explained the malaria patterns as a consequence of El Niño Southern 
Oscillation(30)phenomenon (27) and climate abnormalities (26). Socio-economic, political and 
cultural determinants can also explain the malaria transmission dynamics(18, 28, 29). The primary 
structures of society are powerfully associated with one another and geospatial analyses of these 
variables show strong correlations,thereby offering an explanation for malaria persistence, 
resurgence and the need for innovativeapproaches to elimination and eradication. 
The lowest level of documented malaria cases in Colombia was in 1960, as a consequence of the 
worldwide Malaria Eradication Campaign(20), (31). However, since that time, morbidity has steadily 
increased,with prevalence of Plasmodium falciparum speciesgiving waytoPlasmodium vivaxas the 
most troublesome species. Recent analyses clearly show a seasonal cycle of thirty years; starting 
with thelow incidence of malaria in 1960 after eradication was introduced, and reaching maximum 
incidence between 2000 and 2005, similar to peaksbetween1950 to 1955, just before the 
eradication era. All this evidence suggests that Colombia needs new strategies and programs to 
controland possibly eliminate malaria. Any new initiative must take account of several factors. First, 
Colombia is still experiences political unrest in endemic regions, with poor economic growth and 
socio-ecological conditions suitable for malaria transmission. Second, pre-elimination and 
elimination in Colombia need continuouscontrol programs and ongoing human resource 
management and training, accompanied by adequate health service planning strategies at national 
and local levels as well as modern technology for evaluation and monitoring. Third, the surveillance 
system must guarantee a high level ofdata quality and make sentinel surveillance for prompt 
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malaria detection a priority. Reports of parasite resistance and treatment failure in infected patients 
are limited.  
A successful push towards elimination must includeongoingupdates of the census andof the 
population at risk. The last census in Colombia was carried by 2005 and most of the population at 
risk denominators in useare projections —a situation thatlimits accurate forecasting and appropriate 
development of malaria indicators. We rely on estimations of these data as surveillance systems 
are weak and health workers’ access is limited, especially in areas experiencingserious political 
unrest and terrorism. In other words, current malaria reportinglikely underestimates the real 
situation in endemic areas. 
Malaria transmission dynamics in Colombia corresponds to thetropical conditions inthe affected 
areas, these being less than 2,000 meters above sea-level in 85% of rural areas. The afro 
communities of the Pacific Coast and several indigenous communities in Caqueta and Putumayo 
(Koreguajes), Guajira (Wayus) Catatumbo region (Motilones) and Uraba region (Zenues, Emberas) 
are the most affected populations, where ethnic and cultural plurality are massive.Mass internal 
migration, mainly due to forced displacement fromendemic tonon-endemic areas, has also 
contributed to malaria’s resurgence. Unplanned colonization and the indiscriminate exploitation of 
resources and the environment have had a considerable impact on malaria, primarily through 
deforestation. The economic development models implemented so far have not improved poverty 
conditions in rural or urban areas. Inequities persist and municipalities in categories 4 to 6,1all 
facingthe same difficulties and inequities, have high transmission levels ofmost communicable 
diseases due to poor investment in health and development projects.  Municipalities are 
categorized by level of decentralization and poverty. Map 1 presents the geo-spatial distribution of 
malaria in Colombia. 
1 The municipal category is a synthetic development index designed by Colombia’s National Planning Department (NPD). 
Municipalities in categories 5 and 6 are less economically developed than municipalities in categories 1, 2 and 3. Such 
stratification considers 14 requirements to classify a municipality as decentralized and able to manage their own health 
budget.  
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Map 1.Spatial malaria distribution in Colombia.Source: prepared by the author 
The Global Malaria Eradication program was implemented in 1956 under the dictatorship of 
Gustavo Rojas Pinilla2. It assumed a vertical structure from the beginning, aided by financial and 
technical support from international agencies. Given the political conditions at the time, the program 
worked like a military operationand possesseda suitable administrative, technical and operational 
structure. The program underwent severalchanges in the mid-1960s due to evidence of anti-
malarial drug resistance in Tumaco, on the Pacific Coast (1961). The 1960s were also 
characterized by the emergenceof social resistance movements. Budget constraints led to malaria 
personnel organizing themselves to form a labor union(ANDEMINSAP) that supported strikes and 
causeddisruptionsduring control activities. At that time, personnelwere also assigned to other 
control measures and responsibilities, such as for yellow fever, dengue and vaccination campaigns. 
As a result, Colombia experienced increased malaria incidence rates from the 1980s onwards. 
In spite of the limitations of under-reporting, whichprevents a full understanding of the trends and 
dynamics of malaria transmission, malaria in Colombia shows three main trends during the second 
2 Decree No. 2968, Ministry of Public Health with recommendations of the Public Health Cooperative Service , 8th General 
Assembly of the World Health Organization 
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half of the 20th century: (i) reduced mortality, (15)a steady increase in morbidity, and 
(15)considerable variation in the ratio of confirmed P. vivaxto P. falciparum malaria cases (32),(33).  
Figure 2 shows the reduced malaria mortality rate, which fell from 2.5 per1,000 in 1978 to 0.4 
per1,000 in 2005. The main factors associated with the malaria campaign’s success included 
tremendous financial support from both the state and international health agencies; appropriate 
administrative, technical and operational structures; good supervision and evaluation at all levels; 
and favorable reception by local/affected communities. Unfortunately, othermajor factors persisted, 
including: limited action to promote awareness of the illness, its transmission mechanisms and the 
need for preventive measures; precarious housing,often located in flood-prone areas; poor health 
service infrastructure in rural areas and associated isolation (poor roads and communication 
networks), low education and economic development levels and disorganizedpolitical participation 
in government spheres(18).  
At the beginning of the 1970s, the malaria control program received little in the way ofinternational 
financing and human resources. The decade was characterized by mass, disorganized 
colonization,which left few resources to adequately cover eradication efforts in the affected areas. 
At the same time, consolidated areas were unprotected and received limited advice/counseling for 
controlling epidemics in colonized areas. There was insufficient monitoring and diagnosis, low 
interest in health organizations, poor inter-sectoralcommunication and collaboration(because they 
no longer represented votes), decreased training resources at all levels and insufficient 
awarenessand prevention measures. Technical problems were exacerbated by increased vector-
resistance to insecticides and parasite-resistance to medication. 
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Figure 2.  Colombia’s mortality rate due to malaria,1978-2013.Source: prepared by the 
author with data from the Vector Borne Diseases Program at the Ministry of Social Protection of 
Colombia, 2013 
1.3.2  The current malaria situation in Colombia 
In the late1990s, the malaria control program changed itsapproach,moving from a vertical to a 
horizontal control program. The old and new government departments created by the 1991 
constitution assumed all functions and plans related tocontrol, not only for malaria but also for other 
endemic vector borne diseases like dengue, leishmaniasis, yellow fever, etc.  Colombia ranks 
among the countries with the highest malaria incidence in the Americas, witha relatively high 
percentage of Plasmodium vivaxcases andPlasmodium falciparum being the most pathogenic in 
areas less than 1,800 meters above sea level. Falciparum malaria transmission was reduced by 
85% due to DDT spraying during the malaria eradication campaign.  
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Since the National Malaria Control Program’s(NMCP’s) inception in 1970, security concerns have 
prevented NMCP from covering many areas of the country. Areas particularly at risk of malaria 
include the lower Cauca River region, the tropical areas of the Pacific Coast, the highSinu River 
region and the Urabaregion. More than 160,000 cases were reported in 2003. In 2005, the National 
Surveillance System (SIVIGILA) recorded 107,866 malaria cases: 46,771 cases of P. falciparum 
and 79,101 cases of P. vivax(34). 
Nowadays, financial support for malaria control activities comes almost exclusively from the Ministry 
of Social Security, which contributed over USD 13 million to malaria control in 2003 (35). Attempts 
to strengthen the national program through the Global Fund have only concentrated on fringe 
municipalities, excluding more than 50% of the mostendemic areas. In accordance with the Global 
Malaria Control Strategy and the principles of the Roll Back Malaria Partnership(35), the MoH 
launched a renewed NMCP in 1998. Its goalsinclude: (i) improved diagnosis and treatment;(15) 
selective vector control including use of insecticide treated nets (ITNs) or mosquito-repellent 
chemicals; (15)mosquito breeding control and targeted indoor residual spraying (36); (v)public 
health surveillance strengthening, including entomological and vector resistance surveillance; and 
(v) intersectoral and social participation.Figure 3 presents the annual malaria incidence by parasite 
species between 1960 and 2015. There is an inversion in the relation of P. falciparum cases vs. P. 
vivax cases fromthe 1970s onwards.  
Figure 3. Annual parasite incidence (21); annual Falciparum incidence (37) and annual 
Vivaxincidence (AVI) per1,000: 1960-2015. Source: author’s calculations from IQUEN and MSP and 
NHI databases 
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. 
The distribution by municipality shows that 511 Colombian municipalities (45% of the total) 
presented evidence of permanent malarial transmission in 2002, and 75% of these registered 
moderate and high risk API.3 Urban malarial incidence has grown during the last decade, affecting 
more than 20 municipalities in which the control program was once successful (38), (39), (34).  
According to the WHO’s 2014 statistics, Colombia registered an infantmortality rate of 0.2 cases 
per1,000 by 2000 (40). Those in theage group 15 to 45 years represented 60% of total cases, 
indicating that those in the most productive age brackets are most affected by the clinical disease. 
The age group5-14 years was the secondmost affected, representing around 22% of cases, 
andhaving a significant impact on school absenteeism. 
The predominant malaria transmission vectors in Colombia are: Anopheles albimanus, Anopheles 
darlingi and Anopheles nuñeztovari. The secondary vectors include A. pseudopunctipennis. All of 
them are highly adaptable, especially under conditions ofsalinity (41). 
Anti-malarial drug resistance depends on the region and most of the related evidence is not used 
during drug-policydecision making. The different approachestaken bylocal research groups on the 
one side and international health agencies on the other make it difficult to consolidate findings, 
mainly because of the varying sources and amountsof financing. 
3The malaria control program in Colombia considers three levels of transmission: high risk is more than 10 cases x 1,000 
and moderate risk is more than 1 case/1,000. 
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CHAPTER II Rationale, Aim, Research Questions, 
Objectivesand Methodology 
2.1 Research aims 
The purpose of this research was to compile qualitative and quantitative information 
associatedwithhistorical concepts and changes in public health strategies aroundmalaria elimination 
and eradicationin the second half of the 20thcentury, and correlate these findings with economic, 
systemic, and epidemiological data and the distribution of poverty-related infectious diseases.This 
process made it possibleto evaluate the factors affecting the success orfailure of relevantpublic 
health policies and to advocate for updatedmodels in the context of the health attention system 
model in both low and middle income countries. The findings could help to improve the successrate 
of current interventions and offer scientific evidence on which to base policy decisionsaround public 
health programs andhealth system reforms. This, in turn, could contribute to more effective 
elimination and control programs at both local and international levels. 
Improvingservice quality and promotingthe supervision, inspection, and surveillance of its functions 
is the essence of public health. Smallpoxeradication contributed greatly to the health and wellbeing 
of millions of people, particularly those in the poorest populations, and is considered to be the most 
importantepidemiological and public health achievement of the 20thcentury(42)(43). Efforts to 
eradicate other diseasesare also underway. Polio is one example; unfortunately, some states 
remain infected with wild poliovirus but are not currently exporting it (Cameron, Nigeria Somalia) 
whileothersare no longer infected by wild poliovirus, but remain vulnerable to international spread 
(Equatorial, Guinea, Ethiopia,  Iraq,  Israel,  Syrian, Arab Republic)(10)(43)(44). Anothergreat 
example is the reduction of rubella casesand regionalefforts to eliminate and ultimately eradicate 
the disease(45). 
The malaria case study presented in this thesis seeks to further the concepts of elimination and 
eradication so as to make further public health progress a reality. 
16 
2.2  General Objective 
To describe, characterize and evaluate the evidence related to strategies of disease elimination and 
eradication, and to compile data and information for malaria, in particular,through developing a case 
study of eliminationfor  endemic regions in Latin America, with special emphasis on Colombia. 
2.3  Specific Objectives 
1. To compile and consolidate primary and secondary information related to malaria control,
elimination and eradication concepts and their transformation over time.
2. To analyze trends inmalaria statistics and data as well as to estimate the frequency and
distribution of Plasmodium spp., both symptomatic and asymptomatic, in endemic areas
with evidence ofmalaria transmission.
3. To evaluate the currentstatusof other historicalelimination efforts, such as policies to control
goiter disease after its elimination from Colombia in1990.
4. To outline a basic plan towards elimination as aframework fornational  and regional policy.
2. 4 Study approach
The present studycombines descriptive information, and analytical comparison between regions 
and populations. Extensive literature review has also beenincorporated in order to complete and 
update the state of knowledgeof elimination and infectious diseases. Chapter III presents the history 
of malaria and the evolutionof concepts related toits control from the perspective of a middle-income 
country (Colombia) that has adopted relevantinternational policies.The methodology consisted of 
anarrative review of the literaturefrom both the 20th and 21st centuries. Chapter IV presents the 
results of a cross sectional study, carried out in tworegions of Colombia, endemic for malaria: the 
Pacific Coast and the Caribbean Coast. The proportion of asymptomatic cases, defined as any 
individual with apositive rapid diagnostic test (15),was investigated bysamplingfour 
villagesinTumaco, threevillagesinBocas de Satinga, and sixvillagesinCordoba.  Chapter V offers a 
narrative review of the history of endemic goiter elimination in Colombia and itsresurgence. It 
describesthe current situation, 30 years after the formal declaration to eliminate the diseaseby 
1990, and the high frequencyof thyroid diseases and excessive iodine consumptionin  a sample of 
130 school-aged children(6 to 14 years of age).  
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The thesis concludes with a chapter on the lessons learnt from malaria control and elimination and 
the public health implications for other elimination plans and for public health related policies in 
general. 
2.5 Study population 
The focus is on the Latin America context and the population atrisk and living in endemic areas for 
infectious diseases of poverty. The main analyses and discussion are about malaria trends and the 
impact of relatedpolicies since 1950, with special attention to the Era of Elimination,during which the 
Millennium Development Goals were implemented.Table 4 presents the most prevalent infectious 
diseases inthis region and the most affected populations. The distribution of the population at risk, 
classification of areas by vulnerability and its main diseases and percent of global burden are also 
given. 
Table 4. Ranking of NTDs in LACs by Prevalence and Distribution(46).Source: Hotez PJ, Bottazzi 
ME, Franco-Paredes C, Ault SK, Periago MR (2008) The Neglected Tropical Diseases of Latin 
America and the Caribbean: A Review of Disease Burden and Distribution and a Roadmap for 
Control and Elimination. PLoSNegl Trop Dis 2(47): e300. doi:10.1371/journal.pntd.0000300  
http://127.0.0.1:8081/plosntds/article?id=info:doi/10.1371/journal.pntd.0000300 
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The population at risk in Latin America in2008, the year ofHotz et al’s analyses,was around 105 
million inhabitants in low-, middle- and high-risk endemic areas. The following countries 
reportedautochthonous cases: Argentina, Belize, Bolivia, Brazil, Colombia, Costa Rica, Ecuador, El 
Salvador, Guatemala, Guyana, Haiti, Honduras, Mexico, Nicaragua, Panama, Paraguay, Peru, 
DominicanRepublic, Suriname  and BolivarianRepublic of Venezuela. 
A case of malaria in Latin America is defined as a patient with fever or any other symptom 
compatible with malaria and with a positive blood smear.  In Colombia, 80% of the territory is 
endemic for vector-borne diseases, with malaria affecting 500 municipalities (See Annex 1). 
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2.6 Research Questions 
This thesis was designed and researchedconsidering four guidingquestions. These questions were 
elaborated from positivist, neo positivist, and critical theory paradigms (48-57).  
The following questions were considered: 
1.The epistemological question:What isthe current knowledge of the problem?
2. The ontological problem:What has actually been achieved?
3. The methodological approach:What information doqualitative and quantitative methods reveal?
4. The axiological difficulty:How do questions of ethics bear on the problem?
Table 5shows the research questions constructed for each level of analysis. From the reality and 
object of study, to the relation between researcher and the level of knowledge about the topic 
selected.Ethical aspects are considered as an additional level of analysis, covering national and 
international regulation and its implications forpopulations affected by malaria. 
Other considerations arise from the main research questions, such as: 
• Poverty relates to income inequality and out-of-pocket payments waste of the population
affected by diseases ofpoverty
• Infectious diseasesarecommunicable or transmissible diseases
• Elimination refers to a country or region that has not experienced transmission for a
minimum of three years
In the specific case of malaria,areductionist approach tocontrol focuses on human protection, vector 
control, parasite detection and treatment.Here, other elements related tothe structure of the society 
are included in the analyses. The risk factors for persistence of a disease are often considered as 
biological determinants; however this study presents other determinants such as socio-economic 
and political aspects of the societal structure and their implications for further innovating policies 
towardscontrol and elimination. 
The author evaluates risk factors according tothe positivist paradigm, whichpresentssome 
limitations as this approach is not sufficient for explaining the complete phenomenon. For 
thisreason,the author draws upon critical theory and historical materialism to offer additional 
interpretations. Completing the broader picturedepended on access to the information published 
and the heterogeneity of population. 
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Table 5. Research questions and paradigms used by the researcher 
Epistemological 
Question 
What is the relation 
between the researcher 
and the things that can be 
known? (Scientific 
approaches to that reality) 
Ontological  
Question 
What is the form or 
nature of the reality? 
(Object of the study) 
Methodological 
Question 
How can the 
researcher discover 
that which can be 
known? 
Axiological  
Question 
For the population 
affected, what is 
fundamentally important 
to investigate? 
How can the population 
contribute and 
participate? 
What is value of the 
investigation?
A 
Positivistparadigmsuggests 
the following questions: 
Is current 
scientificknowledge 
sufficient for eliminating 
and eradicating the 
magnitude and frequency 
of poverty-related diseases 
in low- and middle-income 
countries? To what extent 
has malaria frequency 
been reduced in Colombia 
and Latin America during 
the last 15 years? Can this 
reduction be explained by 
theelimination and control 
strategy in place? 
The Critical Theory 
paradigmrequires us 
to answer: 
How do social, 
political, cultural and 
economic 
determinants 
contribute to 
increasing or 
decreasingthe 
frequency of 
infectious diseases 
(to zero)? 
How areethnic 
minorities and 
vulnerable 
populations affected 
by public health 
problems related 
topoverty and poor 
development 
models? 
How can social 
determination 
contribute to solving 
problemsarising from 
endemic infectious 
diseases of poverty? 
Public health 
problems and 
research questions 
cannot be 
solvedthrough one 
single methodology. 
Quantitative 
methods: 
Is the reduction of 
malaria in Latin 
America and 
Colombia statistically 
significant? 
Qualitative Methods: 
Does the evidence 
from primary and 
secondary data 
support a declaration 
of malaria pre- 
elimination or 
elimination in Latin 
America and 
Colombia? 
In Colombia,health 
research is supervised 
by the MoH. Legal 
aspects thatregulate the 
investigation include: 
1.Decree 8430 1993
2.Resolution 13437,
1991 Creation of Ethics 
Committee by MoH. 
Is this research 
experimental? 
Are human lives or 
patients involved? 
How many people will 
benefit from the results 
of this study? 
Is there any conflict of 
interest by the author? 
In light of the conceptual framework outlined above, the following research question has been 
formulated: 
What qualitative and quantitative indicatorsare required to showthat a countryis closeto eliminating 
and eradicatingpriorityinfectious diseases and which elements must be included in surveillance 
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systems to adequately and permanently evaluate and monitor the status of transmission, to 
maintain transmission rates at zeroand to contain anyimported cases? 
To answer this research question,the author conducted descriptive studies and systematic narrative 
reviews of the scientific literature. Primary, historical analyses of the evolution of malaria concepts 
are presented to shed light onthe state of elimination and eradication in endemic regionsovertime. 
Moreover, results of cross sectional surveys carried out in areas endemic for malaria in Colombia 
are included. Studying theasymptomaticmalaria cases in two areas where the risk of transmission is 
high,helpsone to understand the phases of pre-elimination and elimination of malaria. Policies and 
processes towards eliminating goiter in Colombiaarereviewed to confront the current prevalenceof 
goiter and salt consumption in the country. These two diseases offer contrastingcases of control 
and elimination phases; malaria in acurrent state of elimination, and goiter disease post-elimination 
and with evidence of recrudescence due to excessive iodine consumption and the absence of 
policies to regulate it. 
2.7 Methodology 
Qualitative and quantitative methods were usedto answer the research questions. Please see 
below for details. 
2.7.1 Narrative systematic review 
The first step was identifying the research question. MeSH (medical subject heading) and 
DeCS(scientific descriptor) terms were selected to searchEmbase, Pubmed, Scielo and Bireme 
databases. Documents published inSpanish, English and Portuguese were included in the search.  
MeSHterms included: elimination, control, eradication, diseases or poverty, infectious diseases, 
malaria trends.DeCS (Spanishterms: eliminación, control, erradicación, enfermedades de la 
pobreza, enfermedades infecciosas, tendencias en malaria 
All databases were accessed from the Library of the Universidad Nacional de Colombia and 
captured in Endnote X7. After creating a list of references, the abstracts were read and duplicate 
records were eliminated. The repository of Colombia was consulted, in order to identify and include 
“grey literature”,such asresearch reports and other relevantliterature not published in peer-review 
scientific journals. 
2.7.2 Quantitative Analyses 
Data were captured in Excel. The descriptive statistics included the mean comparison and ANOVA 
of qualitative variables. Qualitative variables were compared using2xn tables. The level of 
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significance was estimated at 5%. The means and proportionswere estimatedusing Stata 13. For 
variables with normal distribution, parametric methods were applied, and non-parametric tests were 
estimated otherwise. Crude and adjusted estimations are shown in tables and figures. 
2.8 Ethical considerations 
This research followed the ethical process as set out by the Colombia Ministry of Health. The 
proposal was approved by the School of Medicine’s Ethics Committee, Universidad Nacional de 
Colombia, Bogota. Each participant was informed about the study’s methods and duration prior to 
any interview or focus group discussion; a health service representative was present to answer 
questions or doubts in all such cases. The study follow the principles of Declaration of Helsinki, and 
the Resolution 8430, Ministry of Health of Colombia, 1993. According to law regulation for 
investigation this project is considered of not risk. 
The informed consent form is shown in Annex 2 
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3.1 Abstract 
Introduction: The concepts of control, elimination and eradication of communicable diseases are now 
structural elements of new global health policies. In the case of malaria, we use both conceptual and 
operational definitions that contribute to reducing the negative impact of this disease on the progress and 
wellbeing of low-and middle-income countries.  
Objective: To trace the historical evolution of malaria elimination efforts, from eradication services to 
current international health policies based on global and regional control and elimination programmes 
trough out  a narrative review of the scientific information. 
Results: These changes reflect the perceptions of health authorities and the scientific community on the 
possibility of eradicating malaria based on scientific developments, existing health policies and 
(un)successful experiences during the implementation of programs to combat the disease in regions with 
varying transmission dynamics and health care models, in particular. 
Conclusion: It is now recognized that in the processes of malaria control, elimination and eradication it is 
necessary to use operational definitions and applied interventions that correspond to geographical, eco-
epidemiological and social-economic determinants, as well as participatory models of assessment and 
monitoring appropriate to the structure of national and local health systems, as basic requirements for the 
success of these programs. 
Keywords: elimination, malaria eradication, health policy, history (source: MeSH, NLM) 
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Evolution of the malaria control, elimination and eradication concepts 
3.2 Introduction 
Malaria is a complex problem for the global health, with more than 250 million clinical cases annually. In 
2012, there were nearly one million deaths, mostly children under five and pregnant women. It is the fourth 
leading cause of mortality, which is significant considering that it is a "completely preventable and treatable" 
disease [1-5], [6, 7] 
Approaches to control and transmission dynamics has shown different results throughout history[8]. From 
the Global Malaria Eradication Program (GMEP) of the 1950s, to the current proposal to take progressive 
steps towards elimination in accordance with the Millennium Development Goals by 2015, each initiative 
has had its own set of successes and failures. 
Changes in the concepts of malaria control, elimination and eradication since their appearance on the world 
stage have been a complex process. International health agencies and local health services have 
consolidated basic operational definitions that allow us to understand how multidimensional conditions in 
endemic countries pose a challenge for programs that aim to reduce the malaria disease burden. 
In the last decade, reductions in morbidity and mortality due to malaria have been associated with the use 
of comprehensive and multilevel control tools ([3, 9], [10]). These programs have benefited from great 
financial investments, a network of highly qualified experts and global coordinating agencies. The guidelines 
proposed by these scientific and financial networks include mathematical modelling of the variables 
associated with persistence and resistance, in combination with predictive models of the effectiveness of 
different control strategies under various scenarios. 
Field experiences have shown limited success of these control measures in terms of effectiveness and 
sustainability over time in areas of high vulnerability[11-13]. Challenges for the scientific community, such 
as treatment failure, outbreaks and imported cases in areas nearing elimination, have become a priority. 
This review aims to build a holistic conceptual framework of malaria control, elimination and eradication 
efforts since the twentieth century and presents various models of reduced incidence (close to zero) for 
regions that have achieved the goal of low transmission. We show that addressing malaria control is a 
complex problem and new approaches should include the use and application of systems theory. 
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3.3 Current definitions of the concepts of control, elimination and eradication 
(Table 1) 
One of the statements that best describes our perception of malaria comes from the World Health 
Organization’s (WHO) World Malaria Report 2010, in which malaria is referred to as "a tenacious, ever-
changing foe” [3]. However, from the Hippocratic era to the middle of the last century, the recognition of the 
magnitude of the malaria burden and the complex factors that enable its resurgence and re-emergence, 
despite the control measures implemented, saw malaria defined as "the most serious communicable 
disease in the world"[14-16] 
Before analysing how the concepts and implementation policies for control, elimination and eradication of 
malaria have changed over the last half of the last century, it is helpful to understand the context of the 
current definitions of these terms in order to compare and contrast with those enacted during GMEP, where 
there was debate over the most appropriate definition of the term eradication and confusion between the 
terms extinction and elimination [17, 18]. Strictly defining these terms not only benefits health programme 
planning and implementation by giving "practical strategic parameters" for execution, but it also avoids 
misinterpretation of the actual goals [18-20],[21] 
Control is an organised public effort to implement cost-effective intervention measures against malaria 
according to the particular conditions of transmission in a defined area [22], to "restrict the movement of an 
infectious agent below the level that would result if individuals acted on their own to control the disease " 
[23]. The control is local but still follows global and national guidelines. For this reason, there may be 
differences in the optimal levels of reduction of disease burden in different regions [24], [25] for malaria to 
stop being considered a public health problem [4]. 
Elimination can be defined as the interruption of malaria transmission in a defined geographic area, i.e., the 
incidence of locally-acquired cases is zero [1], [9, 26]. However, it is inevitable that cases will be imported 
from areas where malaria remains endemic to those areas with no local transmission. This proximity to 
endemic areas and constant movement of people and other socio-economic determinants from these areas 
is called vulnerability[18]. Mathematical models have focused on defining a low level of local transmission, 
which could explains why certain areas can not reach the status of elimination or interruption of 
transmission due to the risks of imported cases. Cohen et al. have proposed the term "non-endemic malaria 
control" as a state different from control, also called "controlled low endemic malaria" and "elimination". 
However, WHO clarified that despite the vulnerability of an area, it may be possible to achieve a zero 
incidence when vector control measures make transmission unlikely[5]. Eco epidemiological and health 
systems, as well as parasite and vector genetics in a specific region, are grouped under the term receptivity 
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[18]. The interactions and effects of vulnerability and receptivity in an area are referred to as the 
malariogenic potential or malariogenic environment. The characterisation of these variables for different 
areas with the presence of malaria has important implications for the development and sustainability of 
programmes. As the magnitude of transmission in a given area decreases, highly sensitive and specific 
systems must be implemented due to the difficulty of detection in low transmission settings [27], [28, 29]. 
For elimination of malaria, the basic reproductive number should be less than one (R0 <1).  (Ro) is the 
"measure of effective transmission of the disease," or the number of malaria cases effectively transmitted 
from a single case during the infection. It is an expression of the efficiency of the vector capacity, host 
susceptibility, and infectiveness of the parasite [3]. 
To declare a country free of malaria, the local case record must be zero for three consecutive years [4]. In 
addition, the re-establishment of transmission is said to have occurred once there is a third consecutive 
local case after an imported case per year, for a period of two successive years for P. falciparum and three-
years for P. vivax[5]. 
Eradication is defined as the permanent reduction to zero of the incidence of infection in the world [4]. Its 
character is binary, that is, a disease can be eradicated or not, although some authors recognise the 
practical impossibility of certifying the absence of the organism and can only make approximations from the 
dynamics of the populations involved: human, vector, parasite [14, 21, 30]. Eradication is considered to be 
the ultimate aim in the on going fight against malaria [31, 32]. 
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Table 1. Features current conceptual and epidemiological aspects concerning the terms elimination, eradication and control. 
Conceptual features Control Elimination Eradication 
Etymology French control testing or inspection Latin ex y limen ‘beyond a threshold’ Latin ex y radix ‘uproot’ 
The Individual. Transmission 
dynamics of infection and 
disease occurrence 
Reducing transmission to a level 
where it no longer represents a public 
health problem or that is acceptable, 
presumably (R0=1). 
Reduction of local transmission * to an 
incidence of zero or a very low default 
level not necessarily zero (R0<1). 
Permanent reduction to zero of the 
incidence of infection (R0=0). 
The Community. Endemic 
cases vs. imported 
Should report imported cases to the 
site of origin as well as the presence of 
locally acquired cases and identify 
contacts. 
Seeks to reduce to zero locally-acquired 
cases and recognises that introduced 
cases are inevitable †. 
There are no cases of malaria in 
the world, neither locally-acquired 
nor imported. 
Geographic area The control is local but guided by a 
global perspective with local and 
regional policy according to each 
situation. 
Elimination occurs in a single country, 
continent or other generally limited 
geographic area with common 
characteristics. 
Worldwide ‡. 
Runtime It is by definition a set of permanent 
measures. 
Being involved with a "threshold", 
elimination is not a final process but a 
reversible, temporary achievement. 
Its achievement depends on the 
time countries and regions spend 
on achieving elimination in 
particular. 
* Local transmission is that indigenous transmission that would persist even if all imported cases were prevented.
† An introduced case is on that is secondary to a known imported case. Locally-acquired cases are those cases secondary to alternative transmission cases. 
‡Regional eradication is an "oxymoron" because of the ever-present risk of importation of the pathogen and the continuing need for control 
measures.Sources:[33-35], [6, 26, 36-47].  Adapted by the aut
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3.4 Brief review of programmes to combat malaria 
To facilitate better understanding, we outline the history of international malaria knowledge starting from 
early last century, its fundamental theoretical basis, approaches to addressing the disease, the failures 
encountered along the way, and milestones in the history of epidemiological and social knowledge, not 
only for malaria but also for other infectious diseases. To do this, we perform a theoretical temporal 
division based on what we consider to be the major events, scientific thought, and health authorities 
during the last century and the present. This division is not strict but didactic and does not intend to 
unify visions or ignore the opinions and disagreements encountered during each period; we recognise 
that they are still valid. 
3.4.1 First half of the twentieth century 
Without ignoring other eras of control, we consider the first scientific basis for malaria control to be the 
nineteenth century developments by Alphonse Laveran and Ronald Ross who discovered the parasite 
that causes the disease and documented its transmission cycle [48]. First, in the Bacteriological Era, 
was the identification of the parasite or causal agent, and later in the Entomological Era, from a 
perspective based on causality and in vivo models, work on Vector-Borne Diseases, including malaria, 
presented models of human experimentation. The control measures used were mainly sanitary 
engineering activities related to the water tanks where Anopheles larvae grow, such as the draining of 
swamps, or local use of physical or chemical methods (such as Paris Green) aimed at larval control. In 
the early twentieth century, the debate was between implementing large-scale vector control campaigns 
to "quickly solve the problem" [49] or investing in local case management and environmental health. 
Examples of such activities include those conducted by private organisations like the Rockefeller 
Foundation, designed to improve sanitation and health in port territories mainly in Latin America and to 
conduct behavioural research of tropical diseases. In Colombia, these commissions had an impact not 
only on health, but also on business decisions and on the policies of the country in border or coastal 
areas. At the end of the First World War, coverage with larval control, insecticide spraying with 
pyrethrum extract and restoration of areas — known to Italian malariologists as bonifica integrale[50]— 
coupled with the use of mosquito nets, microscopic diagnosis and treatment with quinine in the 1930s 
could have eliminated the disease in most Western European countries. However, these control 
measures were only economically feasible in places with significant resources and broad interests in 
incurring the costs for example in industrialised cities or in military camps. "In most rural areas, man was 
powerless to control the disease" [50]. Then, with the emergence of Dichloro-diphenyl-trichloroethane 
(DDT), previously synthesised by Zeidler in 1874, and thanks to the observations of Müller in 
Switzerland in 1939 [51, 52], the first contact residual insecticide to decrease the number of required 
applications was first used during typhus epidemics and later for vector control of malaria. The use of 
DDT and chloroquine in the first era of eradication improved the outlook for rural areas such that there 
was an increase in the drive for global achievements, setting the scene for programmes based on an 
etio-pathogenic approach that marked the second half of the century [53], [13, 54]. 
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3.4.2 Second Half of the Twentieth Century 
This period is the one that perhaps offers the most lessons in the history of disease control. At the end 
of the 1940s, it was thought that malaria control through DDT spraying should be recurring, and the 
views of certain malariologists who believed in that increasing spraying coverage would lead to 
suspending DDT use in the future were not welcome [50]. In 1947, the recommendations of the Pan 
American Health Organization (PAHO) favoured household spraying with DDT in malaria endemic 
regions under local control programmes. In Colombia, these control activities were conducted by the 
Malaria Division of the Inter American Cooperative Public Health Service [55-57]. In parts of the 
Caribbean, with support from UNICEF, these local malaria control programmes were integrated with 
others, with the intention of eradicating Aedes aegypti, the vector of yellow fever and dengue [57].  
However, in 1951, in Greece, experiences with DDT in certain regions showed that once the interruption 
of local malaria transmission had been achieved, spraying could stop but transmission would return 
[58].The time needed to stop this transmission was four years for P. falciparum and five years for P. 
vivax[48]. But the emergence of resistance of Anopheles sacharovi against DDT in Greece suggested 
that the time required to maximise the efficiency of the insecticides and simultaneously suspend 
transmission over large geographic areas should last long enough to achieve these objectives but not 
so long as to allow the vectors to develop resistance[59]. These measures together accounted for the 
basis of what became known as "malaria eradication" in the 1950s. Confidence in the potential 
efficiency of residual insecticide spraying, even over other traditional control measures, led to the 
perception that "there was no time to lose in the eradication of the disease while it was possible to 
control the vector" with the insecticides available [36]. 
In 1950, Uganda held the WHO’s Fourth Expert Committee on Malaria, referred to as the Kampala 
Conference [41]. It recognised the relationship between the disease and the development of affected 
countries, especially in Africa. It recommended that governments make it a priority to implement 
"malaria control organisations " that would reduce the burden of disease in order to subsequently direct 
resources and efforts to other public health programmes. It also recognised the need for financial 
resources and trained personnel to implement these organisations. 
In 1954, the eradication strategy adopted by the XIV Pan American Sanitary Conference was instituted 
in 1955 by the Eighth World Health Assembly, under the Global Malaria Eradication Programme 
(GMEP) [60]. Colombia, adhering to international health policy, created the National Malaria Eradication 
Service [61] in 1956 (8), which replaced the previous Malaria Division and was dependent on the 
Ministry of Public Health. The GMEP had four phases: preparation, attack, consolidation and 
maintenance. The campaign was marked by economic and logistical efforts in the country that, with 
cooperation from PAHO and WHO, sought to educate and empower the people affected and build 
capacity among medical and technical personnel. During the preparatory phase, the territory was 
divided into 18 zones according to its particular ecological conditions, including tropical ecological 
characteristics, the presence of different vector species and the high burden of disease. However, 
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diversity of these features in a given zone made malaria in Colombia a public health problem more 
complex than in other countries in the region and one that was compounded by internal political and 
military conflicts. It is now recognised that this campaign had important implications for the practice of 
malariology, namely to be directed from and coordinated by central agencies that assumed a rigid 
system based on local compliance to the rules issued within the guidelines for spraying homes with 
DDT. However, continuation of other control measures, known at the time as the destruction of larval 
breeding swamps and reducing human contact vector, bites reduction [49] did not receive equal support. 
Moreover, the global nature of the programme was affected by the WHO’s recognition in 1956 that 
existing barriers to proper implementation in Africa (long transmission season, high degree of endemism 
and weak infrastructure) led to low coverage of the programmes on this continent [55]. Some authors 
believe that the "discrepancies" between the Kampala Conference, the GMEP guidelines and low 
coverage of local programmes in Africa [62] were the result of extrapolating local experiences, which 
although successful, only represented a limited number of possible epidemiological scenarios for the 
disease. Other flaws that were recognised during the implementation of GMEP included the creation of 
autonomous services structures dissociated from the general health system and with low adaptive 
capacity, the lack of importance given to reports of parasite resistance to chloroquine, and little regard 
for local cultural characteristics in programme planning [9, 49]. In addition, research on control 
measures and antimalarial drugs declined markedly during the GMEP period. It was before the 
emergence of chloroquine resistance in Thailand and Colombia and the U.S. involvement in the wars in 
Korea and Vietnam that illustrated the continued need for research and prompted resumed efforts to 
develop new strategies for disease control [9, 63].  
Thus, in the absence of results consistent with the overall policy of eradication, which excluded regions 
of sub-Saharan Africa and Madagascar, the need for a pre-eradication period for countries not were 
ready to embark on the goal of eradication was recognized. The period would serve to strengthen health 
infrastructure at the same time as carrying out the preparatory phase. However there were no clear 
models of what the minimum health infrastructure required to achieve these goals should look like. Soon 
the lack of local health services and limited political and financial commitment yielded different 
programme results between regions, mainly characterised by the resurgence of transmission after it 
was suspended in the phase attack. The consolidation phase that followed was the most affected and 
showed the extent of the impact of health systems in epidemiological models of disease transmission. 
Considering the current definition of the concept of eradication, PEGM comprised a "series of national 
malaria elimination often successful"  in which the incidence of local transmission was reduced or 
brought to zero, with the ever-present possibility of importation and introduction of cases and the need 
for continued surveillance and control measures to maintain these achievements. During the VIII and X 
Expert Committees, WHO used an annual parasite incidence of less than 0.5/1000 as an indicator of 
when total coverage with insecticide could be stopped? In this case, the use of a threshold confirms that 
the programmes were aiming more towards elimination rather than eradication as we know it today[64]. 
Based on the limited results obtained, it was decided to extend insecticide spraying activities and in 
many areas the consolidation phase reverted to attack phase [65], while others, declared free of the 
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disease, were expected to support them financially [66].Field workers experienced burnout 
[67]compounded by the redirection of resources by major donors to public health problems deemed 
more urgent, as happened in 1963 when the total revenue fell by more than half because the U.S. 
stopped making contributions to the WHO’s Special Account for Malaria, thereby endangering its 
sustainability .Elsewhere, in order to avoid losing the results achieved during the GMEP, efforts and 
resources were concentrated in areas that were "paradoxically, the least affected" . In 1968,a report 
was published stating that the pre-eradication period was indefinite owing to the nature of control 
programmes [68]. This situation led to the WHO, in 1969, recognizing that the malaria eradication was 
not feasible in some countries and thus they should focus on implementing control measures instead to 
develop "economically viable methods for the complete elimination of the disease "[69]. This statement, 
therefore, is considered to be one of the main manifestations of the global paradigm shift 
fromeradication programmes to control measures. 
Despite limitations in their achievements GMEP found a reduction in the global distribution of malaria, 
increased contact with communities through the establishment of volunteers in diagnosis and treatment 
activities, and successfully influenced health programme planning in some countries [49]. The GMEP 
eliminated the disease in regions at the boundaries of the overall distribution of malaria. The countries 
that achieved elimination shared similar characteristics: political stability, political and financial 
commitment to eradicating malaria, good organisational and technical infrastructure, high quality staff 
training, well-developed and functional general health services, absence of internal and external 
conflicts, and no large population movements from neighbouring countries with malaria. 
In 1972 and 1973,the Garki project took place in Nigeria[70]. This project implemented control 
measures (residual insecticides with propoxur and mass treatment with pyrimethamine sulfalene) in a 
population with high and steady transmission of malaria. The project resulted in a marked decrease in 
entomological inoculation rates, incidence of fever, infant mortality rates and prevalence of parasites. Its 
importance lies in demonstrating the impact of control measures in areas of high and steady 
transmission. In this period, one of the major changes was the understanding of the control measures 
as an alternative goal (reducing incidence and mortality) to the ultimate goal of eradication [71, 72], [73]. 
The achievements of countries between 1950 and 1978 were important on the road to reducing malaria 
worldwide. For example, in the Americas, 22 countries achieved the elimination of malaria in this period, 
37 countries in Europe as well as Japan, Australia and Singapore [48]. During the eighties, many 
countries continued to implement programmes with the goal of "eradication", especially those committed 
to GMEP initially and who were on the edges of the distribution area of malaria. Between 1970 and 
1990, Tunisia, Greece, Kuwait, Libya, Maldives, among others, were certified as malaria free countries 
by the WHO, and achieved elimination just as Europe and Australia had.  
In Colombia, during the National Malaria Eradication Service, there was a significant decrease in 
morbidity in the first five years of program implementation and a reduction in the malaria risk area from 
93% to 85%. However, following this achievement, signs of resurgence and persistence of the disease 
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occurred. This was reflected in an increased annual parasite index [37] from 2.19 per 1000 in the period 
1960-1974 to an IPA of 8.9 per 1000 in the period 1994 -2004 although the annual rate of blood tests 
(IAES) remained consistently below the minimum percentage required for the diagnosis of malaria in 
populations at risk. This was due mainly to the lack of sustainability in the measures used following the 
withdrawal of technical and financial support from international agencies in the1970s, such that the 
country could not achieve elimination status[14]. Differences in achieving elimination between countries 
led to the enactment of theGlobal Control Strategy of the Ministerial Assembly of Amsterdam, in 1992, 
which sought to reduce the impact of the disease in affected countries through control measures 
tailored to local eco- epidemiological characteristics and the health infrastructure and capabilities 
available. 
Subsequently, in 1998 the Roll Back Malaria (RBM) initiative was born to increase the coverage of 
control measures, mainly in sub-Saharan African countries. The RBM was supported by the UN, NGOs, 
the private sector and was participatory at different levels, with the primary purpose of reducing 
transmission or even eliminating malaria from their territories. 
3.4.3 Period from 2000 to the present 
The Millennium Development Goals targets for 2015 recognise many of the achievements to date in 
controlling malaria. Among the related goals, stated either directly or indirectly, are the fourth goal 
(reduce by two thirds the mortality rate among children under five years) and the sixth goal (stop and 
reduce the incidence of malaria and other infectious diseases). The year 2000 gave rise to the Abuja 
Declaration. Held in Nigeria, the summit of African countries sought to cover 60% of the population at 
risk with key malaria interventions by 2005, especially for children under five and pregnant women. 
Some of the control tools that have had the greatest impact to date are the distribution and use of 
insecticide treated nets (ITN), long acting combination therapies based on artemisinin, and rapid 
diagnostic tests. With these strategies, the possibility of eliminating malaria and eradicating it in the long 
term attracted the interest of international political and financial leader sand in 2007, the Bill and 
Melinda Gates presented eradication as the ultimate goal to which global efforts aiming to combat the 
disease should contribute[10]. However, given past experiences and the different transmission states 
where malaria is found in the world, it was not possible to set a timeframe in which to achieve this goal, 
meaning the goal is a long-term one. Currently, the phases described by WHO  for the transition from 
control programs to elimination and finally eradication, are more gradual than those initially promulgated 
during GMEP, which were based primarily on an "attack phase” to reduce the burden of disease. Thus, 
those countries with endemic malaria areas with high and stable transmission and without experience in 
elimination. This need has led to admit that "eradication is not feasible with currently available tools[63], 
[16]. It can be inferred that these tools are useful for countries with low and unstable transmission and 
with experience in elimination programmes, but not for those with high and stable transmission, which 
have remained under the control programme paradigm. 
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In 2008, the Global Malaria Action Plan was approved by the association for Roll Back Malaria and 
aimed to reduce the number of malaria deaths in the world to nearly zero by 2015, eliminating malaria in 
8-10 countries and countries that were in the pre-elimination phase in 2008 and eradicating malaria in 
the long term through progressive elimination in countries [74]. 
According to the WHO, of the 109 endemic countries in 2007, 80 were in the control phase, 12 in 
transition to elimination, 11 in elimination, and 6 in preventing reintroduction [3]. Since 2007, three new 
countries (UAE, Morocco and Turkmenistan) have been added to the list of countries certified malaria-
free by the WHO [1]. Today New Guinea and the tropical African regions are considered to be the last 
endemic epicentres of stable malaria. 
3.5 Concepts of malaria eradication in the twentieth and twenty-first 
centuries (Table 2) 
As we have seen, the term eradication has had different meanings and interpretations over the last 
century. These changes took place gradually as shown in Table 2. It should be noted that this 
comparison uses the term "eradication" as it appears in the literature, so as we saw above, deep 
conceptual differences between the current uses of the term and that used in the middle of the last 
century may exist. Contrasting the today’s definition of "elimination" of with "regional eradication" and 
"elimination" as it had been used over the past century has already been done by others [8]. We believe, 
however, that by explicitly comparing the term eradication as it has been used inanti-malaria 
programmes may allow for a better understanding of the conceptual basis from which these 
programmes were formed. 
 As seen in Table 2, one of the main engines of the last half century that made the world change the 
focus of its programs from malaria control strategies to "eradication" was the appearance of DDT as a 
scientific tool to quickly reduce rapidly the vectors of causing disease transmission. The vision of the 
mosquito and the parasite as enemies to kill is reflected in the military terminology "campaign" to 
eradicate malaria. 
This, coupled with political and economic interests meant that approaches concentrated on fighting the 
vector and the parasite, diverting attention away from the environmental conditions where this was 
taking place[75]. 
Historically, the main obstacles to progress in controlling and eliminating the disease were the lack of 
flexibility of eradication programs, the inability to adapt to the particular regional situation and the lack of 
coordination between the control and research programmes. The role of national epidemiological 
services in achieving long-term sustainable elimination in endemic areas must also be highlighted. 
Many authors recognise the need to invest not only in the technological advancement of control 
measures but also in the epidemiological infrastructure required for data collection, analysis, monitoring 
and surveillance [31]. 
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Accordingly, the understanding of eradication as the triumph of man in the process of understanding a 
disease that has existed for centuries, the biological characteristics of all actors involved and "its close 
relationship with certain conditions of life and work and with certain production processes "indicates that 
the perception of the term today differs greatly from that of the scientific community and health 
authorities of the last century. At that time, although determinants of disease transmission and biological 
control had already been recognised, the definition and implementation of eradication programmes were 
contingent upon the use of chemicals. Understanding eradication beyond this approach is perhaps the 
most important achievement in the history of programmes combatting malaria, so that even to achieve 
elimination, countries are required to maintain a "sustained commitment to medium and long-term 
health systems and required human capacity", as stated by the WHO [1, 2]. 
The experiences of malaria eradication programmes, has allowed us to design programmes for the 
eradication of other transmissible diseases and to coordinate based on the various determinants and 
structures of health systems with successful results, as with the Intensified Smallpox Eradication 
Program [29, 76]. The various cost calculations for smallpox eradication programmes were favourable; 
when eradication efforts began; transmission of the disease was already reduced in several countries. 
Unlike malaria, certain characteristics were present and responsible for the success of these smallpox 
eradication programs, like the development of immunity, the availability of an effective vaccine, the 
characteristic clinical picture and the possibility of surveillance. For the Polio Eradication Program, 
begun in 1988, there has been a substantial reduction in the incidence of the disease and a reduced 
number of polio-endemic countries (from 125 in 1988 to 6 in 2003), but it is necessary to recognise that 
in some African countries, weak health infrastructure, communications, transport, among other things, 
have prevented the interruption of transmission [21]. 
Currently, we identified a number of key considerations for choosing between eradication approaches 
that are (a) scientific: available technologies to interrupt transmission and interventions to affect the 
host's ability to fight disease (b) focus on operational biological systems of the parasite, vector and host, 
and (c) economic: finance, time duration and geographic region of concern (14). Multidisciplinary and 
intersectoral approaches, biosocial-models, and systems theory approaches as suggested by Valero et 
al. (33) are also proposed. The active participation of communities is essential for monitoring, inspection 
and control programmes. 
Figure 1 compares the phases of GMEP and the stages currently recommended by WHO for countries 
with low to moderate endemic patterns. Although the term eradication 50 years ago is now recognised 
as elimination, these two graphs show significant adjustments in phases or requirements of moving from 
control to elimination. Although the technical details may vary between the two models, a retrospective 
analysis found similarities, such as the maintenance phase of the First Elimination and prevention of 
reintroduction of the New Elimination and consolidation with elimination. The main difference, apart from 
the conceptual definition of "eradication" would then be in the preparatory and attack phases, which 
could be related to current control measures (to rapidly reduce the burden of disease). It is remarkable 
that 50 years ago, the time spent on the preparatory and attack phases was 5 years before moving on 
39
to the consolidation phase, while nowadays we do not known how long it will take countries to achieve 
the "first reorientation of its programme" towards the pre-elimination stage. As discussed below, there 
are countries that are limited in their ability to progress towards elimination, thus control could be 
considered as an alternative to the goal of elimination, not theoretically but from a pragmatic point of 
view. 
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Table 2. Global overview of malaria and transformations in the concepts of eradication 
Period Late nineteenth and early 
twentieth century 
1940-1969 1970-2000 2000-2011 
Global malaria situation 
Health policies Local control programmes. Global Malaria Eradication 
Programme (GMEP) 
Reorientation of control 
programmes. 1998: Roll Back 
Malaria Initiative 
Millennium Development 
Goals. Funds and research 
agendas in the accelerated 
elimination phase and 
eradication as the ultimate 
goal. 
Scientific developments Discovery of the parasite cycle, 
first residual insecticides, use of 
quinine. Development of 
mathematical models of 
transmission. 
Development of new antimalarial: 
chloroquine, amodiaquine, proguanil, 
pyrimethamine, Appearance of the 
first cases of resistance. 
Artemisinin Development (1972), 
mefloquine (1985). 
Development of ACT*. RTD*, 
long-lasting, insecticidal 
treated nets.  
Interpretations of the term eradication of global malaria cases 
Geographic area 1916: Eradication of malaria in 
the Western hemisphere 
Eradication applies to specific local, 
state, national, and regional areas 
and extends to the periphery to all 
areas from which there may be 
reinfection. In practice, there are 
areas where eradication is not 
feasible. 
Eradication can only be global. 
Regional eradication is therefore 
an oxymoron. 
2007: Global level. 
Certification of freedom from 
malaria is given to countries 
and there is a recognised 
need for joint support between 
regions. 
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Estimated time Since control measures were the 
paradigm of that time, deadlines 
had not been set for the 
sustained reduction or 
eradication of malaria. 
It is a time-limited campaign that wills 
last 4-5 years, followed by three years 
of consolidation.  
It is recognised that eradication 
cannot be conceived as a short-
term programme. 
Eradication is a long-term, not 
a short-term goal. 
Incidence of infection Mainly, sought reduction in 
morbidity and mortality in specific 
areas. 
Eradication seeks to end malaria 
transmission without resumption at 
the end of it. WHO* later set a 
threshold of "manageable 
proportions" based on API *<0.5/1000 
and in 1964 <0.1/1000. 
Reduction to a level that does not 
constitute a public health problem. 
2007: Permanent reduction to 
zero of the incidence of 
infection through the 
progressive elimination of 
malaria in countries. 
Pathogen situation For control measures to prevail, 
we would expect significant 
reductions in transmission 
incidence of certain pathogens 
without the cessation of 
transmission. 
1961: You can not survive even a 
single pathogen ("Sunset/extinction") 
No possibility of reintroduction of 
the pathogen from another 
geographical area. 
2006: In practice it is 
impossible to certify the 
extinction of the parasite with 
certainty. 
Need for control 
measures 
There has been controversy 
between the vector control and 
drug administration vs. 
investment in local health 
systems and economic 
development. 
1952: There is no need to continue 
with residual insecticides. 1962: 
Eradication is maintained even in the 
absence of any preventive measures. 
1969: Control measures are 
necessary and valid in regions where 
eradication is not feasible. 
1984: In the case of regional 
eradication, there is no need to 
actively monitor control measures, 
monitoring and rapid response to 
imported cases; are able to keep 
the area free of disease. 
2007: The new strategy is to 
move quickly with the tools 
available while researching 
new developments. 
* Abbreviations used: API Annual Parasite Index, WHO World Health Organization, RDT rapid diagnostic tests, ACT artemisinin-based combination therapy.
Sources:[3], Adapted by the authors. 
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Global Malaria Eradication Programme 
(1955-1969)  
Incidence <0.1/1000 
0 local cases for at 
least 3 years 
Preparatory Attack Consolidation Maintenance 
1 year 4 years Duration varies Duration varies 
Improving infrastructure, 
personnel training, 
geographical research, 
epidemiological and 
entomological. 
Vector control, 
treatment, 
surveillance, 
detection and 
tracking of cases. 
Focused studies. 
Coverage of the 
health system and 
surveillance. 
Focused control 
measures. 
Interruption of local 
transmission. 
Surveillance, 
identification of 
imported cases, 
prevention of 
outbreaks. 
Phases indicative of the elimination of malaria in endemic countries or areas 
with low or moderate transmission (2007)  
API*<5% in 
weak cases 
Incidence <1/1000 in 
at-risk populations 
0 locally acquired cases 
for 3 years 
Control Pre-elimination Elimination 
Prevention of 
reintroduction 
1
st
 reorientation
2
nd
reorientation 
Reducing the burden of 
malaria. Increased 
coverage with control 
measures and clinical 
services. Strengthening 
health systems. 
Strengthening 
epidemiological 
surveillance, 
classification of 
outbreaks. 
Interruption of local 
transmission.  
Protection of 
vulnerable spots 
with control 
measures, 
monitoring and 
identification of 
imported cases. 
Figure 1. Comparison between the GMEP phases and the phases set by the WHO for 
certification of malaria-free status. Sources:[48], [50].Adapted by the authors. 
* Abbreviations used: RDT positive index sheets or rapid diagnostic tests.
Main tools currently available 
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Figure 2. Current tools for and main goals of control and elimination. Data based on reports of 
malERA group (Malaria Eradication Research Agenda initiative). 
* Abbreviations used: G6PD glucose-6-phosphate dehydrogenase, DM diagnosis by microscopy,
RI residual insecticides, ITNs insecticide treated nets (long-term), ACT artemisinin-based 
combination therapy, intermittent presumptive treatment IPT. 
Sources:[1, 3],[3], [77-86], [87]Adapted by the authors. 
Vector control 
RI*, ITN*, 
larvacide, 
environmental 
control 
Diagnostic 
Clinical 
diagnosis, 
RDT * for P. 
vivax and P. 
falciparum 
DM *, 
molecular 
and 
serological 
tests. 
Drugs 
ACT*, quinine, 
primaquine, 
sulfadoxine-
pyrimethamine for 
IPT* in pregnant 
women among 
others 
Epidemiological 
surveillance 
Public health 
surveillance, 
reporting and 
investigation of 
cases, and 
monitoring 
antimalarial 
resistance and RI 
Health systems 
Different models 
of systems with 
different equity, 
access, and 
quality indicators 
Other conditions 
associated with 
the presence of 
disease. 
Main needs in relation to current tools 
New 
interventions in 
cases of 
exophilic and 
exophagic 
vectors and in 
areas of high 
transmission, 
ideally one 
application with 
long-term effect 
(genetic 
modification). 
Quality 
control for 
RDT and DM 
in the field 
and PDR that 
is more 
sensitive, 
easy to apply 
in states 
asymptomatic 
individuals at 
low parasite 
density and 
identify 
individuals 
with G6PD *. 
Maximize available 
drugs and develop 
new ones that can 
be mass 
administered in a 
single dose, effective 
against all stages of 
the parasite and its 
species and with 
specific indications 
for age group and 
type of programme.
Improve 
information 
systems to 
monitor changes 
in pathology and 
epidemiology 
using mobile 
telephone or 
internet to limit to 
rigorous 
transmission. 
Research on 
health systems 
with universal 
access, equity 
and effectiveness 
in the delivery of 
services at all 
levels. 
Integration of 
diagnostic tests in 
health services. 
Social science 
research and 
education in 
community 
participation on 
vector control and 
environmental 
planning 
Current goals 
Control Programmes 
2000 Abuja Declaration, Millennium Development Goals 
2005: Reduce the number of malaria cases and deaths by 
2000 by 50% in 2010 and 75% or more (almost zero) in 
2015. 
2008: Countries in areas with high and stable 
transmission can proceed to large-scale front measures to 
reduce the intensity of transmission. 
2011: Coverage for 80% of the population at risk with 
control measures. 
Elimination Programmes 
2007: Shrinking the malaria map. 
2008: Countries in areas of low and unstable transmission 
can proceed to malaria elimination. 
2011: Eliminate malaria from 8 of the 10 countries that are 
in pre-elimination phase by 2015. 
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3.6 The future of malaria: From defining concepts to the real success of the 
programmes
One of the assumptions for eradicating malaria is that there is no animal reservoir that can interfere and 
cause resurgence inhuman transmission [10]. Understanding this limited epidemiological characteristic in 
humans has been reinforced by the impact on the incidence of disease transmission of control measures 
that act primarily on the triad vector, man, and parasite. However, even during the GMEP,the results 
obtained from such a view were far closer to the goal of achieving a sustainable and time-limited campaign, 
reducing case incidence to zero. The teachings of GMEP have been well documented [49], however, in the 
face of eradication proposals and discussions that have been reintroduced in this millennium, it is necessary 
to consider the following: 
3.6.1 Strict focus on humans, the parasite and the vector and the possibility of eradication 
Historically, man's fight against malaria has been strictly biological but always influenced by the social and 
cultural characteristics of different regions. This means that theoretically at least, it is recognise that 
eradication depends on more than just the effectiveness of the control measures employed. Control 
measures are effective when they reach a coverage level of at least 80% of the population and are essential 
in the early stages of vector control for reducing malaria morbidity [88]. Indoor spraying with residual 
insecticide plays an important role in the process of elimination as it is intended to terminate the viability of 
the remaining pockets of transmission. 
Thus, during the "New Age of Malaria Elimination ", we consider additional measures to promote malaria 
eradication. Research areas include vaccine development, genetic modification and the possibility of action 
blocking drugs on transmission (in single doses) to replace artemisinin-based therapies [10]. It is important 
note that, unlike GMEP, the current trend is toward recognising the limitations of existing tools and the need 
for developing in parallel a research agenda with one of control. 
Still, even though today there is growing consensus regarding the need for infrastructure investments in 
health and epidemiological services, scientific research seems to be directed mainly to developing chemical 
compounds with specifications dictated by international agencies. These details include chemical 
composition, ease of use, effectiveness, dosage, limited therapeutic properties (in terms of pathogens, 
treatment therapy versus intermittent presumptive therapy, among others) and rapid diagnostic tests with 
lower costs and better results in the field (currently rapid diagnostic tests for P. vivax have lower sensitivity 
and specificity for P. falciparum, so the case deserves special attention, requiring a treatment regimen that 
includes drugs with action against hypnozoites. The interest in focusing efforts and resources on these 
measures is based on the importance of ensuring sustainability of the results obtained with current control 
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measures, in terms of significant reduction of the burden of disease and eventual elimination in certain 
geographic areas [74], [88]. However, control measures based on chemical compounds appear to have a 
lifespan, within which the benefits are undeniable, but once there are biological responses by the organisms 
where they work or are new circumstances that reduce its effectiveness, the results are also potentially 
short-lived. 
Since the temporary nature of these chemicals’ effectiveness has been recognised, it is questionable 
whether this methodology is prolonging indefinitely a strategy for action - reaction between organisms in the 
transmission dynamics and pharmaceutical science. While the focus of the fight against malaria requires 
measures for each of its components, vector control is imperative(with measures other than the use of ITNs 
and residual insecticide spraying).A balanced global approach is perhaps more effective and less costly if it 
relies less on biological adaptations of the vector and parasite. Thus, although theoretically we have taken a 
big step forward in advocating a comprehensive approach to malaria (as well as other infectious diseases), 
in practice it is still necessary to expand interest and redirect efforts towards improving all conditions that 
influence its persistence. 
3.6.2 What to expect from malaria programmes in accordance with the current tools and outlook 
One question that arises amidst the achievements is which the way forward is[67]. According to WHO 
models, designed based on efficiency studies of current control tools and assuming that all things remain 
the same, with the tools currently available, it is possible to effect substantial changes in the global map of 
malaria. Such changes consist of a75% reduction in the incidence and age redistribution of malaria cases. 
Under this scenario, the decrease in the number of people at risk in the world would also increase the 
proportion of countries that can transition their programmes towards elimination. However, since the main 
malaria programmes are geared towards achieving this goal, many scientific authorities have noted that the 
changes we expect to see in the endemic characteristics of certain regions represent operational challenges 
that test the continuity of interest and support from the international economic and political organisations. 
These challenges include changes in the pre-test probability associated with changes in the prevalence of 
the disease [10]; the significance of changes in immunity associated with the variation in intensity of the 
exposure periods of individuals; the impact of new epidemiological characteristics on measures to reduce 
the rate of infection or clinical disease, such as those aimed at sporozoites and asexual forms of the 
parasite [85]; the increase in costs per case treated as incidence decreases; and reducing the percentage 
of the population at risk and therefore the need for measures such as Intermittent Presumptive Treatment in 
children and pregnant women [82], among others.  
In addition to these factors that require authorities to adapt to prevailing new epidemiological conditions, 
today it is recognized that although the financial contributions from international funds increased during the 
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period 2004 - 2009, the 1.800 billion dollars raised in 2010 were far from the 6 billion dollars required to 
achieve global coverage. Thus, the WHO has deemed the achievements of current control measures as 
"sustainable, but fragile" [82]. Figure 2 shows the tools that are currently used in control and elimination 
programmes and the major challenges facing current research agendas. 
In the context of current strategies, the process to follow involves the progressive reduction of malaria 
transmission from local levels ("natural margins in endemic areas where the disease is not as entrenched") 
to regional and global, leading to what has been called "Shrinking the malaria map”, as different states of 
transmission currently existing each country (control, pre-elimination, elimination, prevention of 
reintroduction) [89], [90]. This becomes important when you consider that many endemic areas with high 
and stable transmission of malaria have not had successful experiences with control programmes and 
therefore cannot even reorient their programs to pre-elimination stage. Some authors have focused on other 
areas in which malaria transmission is heterogeneous, because the malaria community is particularly 
looking for the appropriate distribution of resources, combining elements of control and pre-elimination and 
not exclusive programmes [91], [92].  
Furthermore, it is recognized that reorienting programmes towards elimination requires a joint commitment 
of countries in the same region as reducing the transmission of malaria in border areas decreases the 
possibility of imported cases and thus the threat to local achievements[93]. In this particular situation, one of 
the points in favour of collaboration between countries in the same region is that despite the large economic 
investments required to implement eradication programmes, it is less costly to "prevent the reintroduction of 
border cases than to indefinitely maintain control measures on a large scale " [94]. Some reports, for 
example, mention the utility of planning an elimination programme in cases where socio-political conflicts 
and displacement hamper authorities’ access to areas with populations at risk. Although the goal of 
eradication, put back on the table in this millennium, sought to incorporate control programmes and 
elimination as the most important goals for eradicating malaria, gaps remain in developing methods for 
monitoring remote areas, identifying barriers to access to health systems, and generating greater 
investment in developing diagnostic and immune prophylactic methods, particularly for cases of residual 
malaria in specific regions [61], [86]   
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3.7 Conclusions and recommendations 
The purpose of this review was to highlight and to trace the historical development of fields of knowledge, 
from the periphery to the centre, that have characterised the process of constructing the terminology used in 
the control, elimination and eradication of malaria. However, it is important to mention that malaria is a 
complex public health problem in which there are various interacting determinants, health system actors 
and dynamics between multiple levels, making the process of reconstructing these concepts somewhat 
challenging [95]. 
This review evidence how these approaches and concepts emerged and transformed during a period of 
great social, political and economic change in the 20
th
and 21
st
centuries. It identifies some of the factors and
actors associated with the shrinking global malaria map, in time and space. The reciprocal relationship 
between the definition of concepts and the implementation of programs in the history of the health policies 
of malaria in the first two centuries suggests: first, continuous learning by international and regional 
scientific and health authorities; second, and no less important, the possibility of innovation in interventions 
from basic research to public health practice with approaches that complement existing measures as they 
delve into the different malaria scenarios; and third, the consequent enrichment in planning new strategies 
to reduce the problem and in the definition and achievement of objectives at different levels of intervention. 
The state of the art shows limitations in financing to make sustainable the elimination planning and the main 
challenges include the control of case importation, the limited evidence of self-medication in poor areas 
where health system can not guarantee enough coverage of prompt diagnose and early treatment as well 
as barriers of access in remote areas under political unrest. Most of these endemic areas where malaria 
persists do not have adequate surveillance systems and monitoring indicators.   Understanding the complex 
determinants and intrinsic and extrinsic relationships that influence resistance, resurgence and persistence 
of the disease have been previously studied and have described malaria as a disease "intimately 
associated with poverty, without having a causal relation or being of direct consequence " [30]. Thus, the 
challenge for the malaria community is not only technological innovation but also other cost effective 
operational measures, so that some countries can reorient their programmes towards pre-elimination, 
unless these new scientific tools radically change the way we see malaria transmission, as was the case of 
a vaccine that specifically targeted parasitic states to influence transmission or/in consideration of the 
complex genetic and antigenic characteristics of the parasite and therefore development of immunity. For 
these countries especially, the research strategy for new control measures can be harmful considering that 
a large part of health efforts are directed to this work. 
Community participation in the process of organizing programmes and prioritizing areas according to 
vulnerability is important[61]. Additionally, empowering and constructing social networks facilitate and help 
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to improve processes such as diagnostic methods, mosquito net distribution, surveillance of areas 
experiencing a resurgence of cases, and proper distribution of resources. Monitoring and evaluation should 
include representatives of these networks who would participate in periodic evaluations carried out by the 
public and private health authorities involved in the next stages of eradication, elimination and control. 
In addition, and not less important this elimination Era has the priority to reduce the environmental impact of 
insecticide massive use as well as improve the coverage of the programmes in cluster areas where limited 
changed of data and statistics have been demonstrated. 
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4.1 Abstract 
Objective: To establish the proportion of asymptomatic malaria cases in two endemic 
areas of Colombia and compare the findings of malaria elimination with other endemic 
areas in the region. 
Methods and Population: Cross-sectional surveys were carried out in2011 and 2014 in 
two endemic regions of malaria inColombia, the Caribbean and Pacific Coast. Informed 
and written consent were obtained from each volunteer. Capillary blood samples 
wereobtained and examined through microscopy and RDT. Temperature was measured 
from the ear and a socio-demographic and clinical questionnairewas completed for each 
patient. In addition a narrative review was conducted to correlate state of malaria 
elimination in Colombia in comparison to other countries of the Amazon Region. 
Results: A total of 548 volunteers were sampled by active case detection in Cordoba 
and Nariño.The proportion of positive malaria cases was3% (17/548).Malaria mixed 
infections were the most prevalent event at 47% (8/17).  Fever prevalence,that is 
temperature over 38.0oC, was 2.7% (15/548), but only twofebrile patients testedpositive 
for malaria. The prevalence of asymptomatic malaria cases among all positive cases 
was 88%. Studies about subclinical malaria are limited on the region. The financial 
resources impact the sustainability of control programs in several countries in The 
Americas and surveillance system is major responsibility at public health sector. 
Conclusion: Asymptomatic malaria cases and mixed infections represent the main 
challenge for malaria control and elimination programs and public surveillance systems 
in Colombia. In regions with dense populations and high migration levels, vulnerability to 
infection is high. The presence of imported cases affects control and elimination efforts, 
reducing the Basic Case Reproduction Rate< 1. Similar results have been found for the 
countries from the Amazon Region. Innovation in surveillance and innovation in 
community participation are required. 
Key words: malaria elimination, febrile, malaria control, asymptomatic, active case 
detection,surveillance, mixed infection 
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4.2 Introduction 
Malaria persists as the major global public health problems. Traditionally, solutions have 
centered on a biological approach, such as treating the parasitic infection and vector 
control, without taking socio-economic and environmental factors into account. This 
paradigm has proved insufficient for advancing control strategies and progressive 
elimination.The main challenge has been early diagnose and prompt treatment. 
Unfortunately, failure treatment in clinical cases and adhesion to radical  affect the 
process, outcome and impact indicators of control programs. 
In Latin America, the first chloroquine resistance case was registered in Tumaco, 
Colombia in1960. (1), (2). One possible factor contributing to the spread of drug 
resistance in the region was the frequency of presumptive treatment for all febrile cases 
without follow up, and not radical treatment for all positive confirmed cases (3), (4), by 
first Eradication Era . More recently the failures treatment are associate to poor 
treatment adherence and self-medication with natural herbs as a consequence of limited 
access to health malaria services (5).  
New global malaria elimination efforts guided by the WHO’s Global Technical Strategy 
(WHO, 2015) and RBI’s action and investment framework (6) (RBM 2015) point to 
several key elements, including better knowledge of malaria epidemiology patterns at 
different endemic levels, which can be used to estimate the potential impact of novel 
malaria reduction strategies (7),(8),(9).Integrated strategies tailored to specific endemic 
settings, such as combined therapies, intermittent preventive treatments (IPT),and rapid 
diagnostic testing(10),have been shown to reduce case-fatality rates associated with P. 
falciparum.(11), (12), (13). However, this is not the case for P. vivax, owing to its 
dormant forms in the liver and the possibility of relapse, and to the reservoir of 
asymptomatic cases. In addition, the high rates of mixed malaria infections in countries 
like Colombia limit the possibilities for elimination. Mixed malaria infections are widely 
correlated with inadequate treatment and self-medication, with limited quality control 
strategies for blood samples, and with considerable difficulties accessing health 
services, thereby preventing patient control during the pathogenic period(14, 15). 
In Latin America, global pre-elimination and elimination strategies have led to the 
introduction of various integral strategies at three levels: parasite, host, and vector (16), 
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(17). In this context, (i) few studies have considered the impact of asymptomatic cases 
on the basic case reproduction rate (Ro), and (ii) there is still a need to define and 
quantify the proportion of fever attributable to malaria and its implications for elimination 
in different endemic settings(18-23). The purpose of this study was to explore the 
association between malaria infection and fever as a potential way of tracking progress 
towards malaria control and elimination in low endemic areas and to compare the 
changes in species’ transmission patterns. To do this, we assessed the level and 
distribution of symptomatic and asymptomatic cases and related the findings to potential 
transmission risks as a basis from which to develop improved models of control and 
elimination in Colombia.  
4.3. Methods and study population 
The study was conducted in two endemic areas in Colombia: Nariño, department on the 
Pacific coast, and Cordoba, a department on Caribbean coast. Blood samples were 
obtained from both urban and rural areas of Nariño in San Andres de 
Tumaco(1°48′24″N 78°45′53″W) and the municipality of Olaya Herrera (2°20′49″N 
78°19′32″W). This region is endemic for falciparum malaria in a 80% and  population is 
mainly Afro-Colombian.In Cordoba, the study concentrated on Puerto 
Libertador(7°53′17″N 75°40′18″W) and the municipality of Montelibano(7°58′16″N 
75°25′05″W), both endemic areas for vivax malaria but high prevalence of transmission 
of other vector borne diseases. Cordoba department registers 9% of total positive cases 
detected by the National Malaria Surveillance System of Colombia(24).  
A complementary qualitative systematic review was conducted, using Embase, 
Pubmed, and Bireme databases, covering the period 2000-2015. Search terms included 
asymptomatic, fever attributable to malaria, elimination, eradication and control of 
malaria in South America and Colombia. Several search equations were elaborated to 
obtain more precise information related to malaria elimination and control indicators. 
The references were captured in Endnote X7 and Zotero. Duplicate records were 
identified and eliminated. All abstracts meeting the inclusion criteria were read and 
selected for complete analyses of frequency and association measures. 
We compared cross sectional surveys conducted in 2011 and 2014, and 1995cross 
sectional survey data for San Francisco village(25).This dataset was presented by the 
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World Malaria Atlas (26). This area was classified as an high endemic risk (API >100 
per 1000 in habitants); unfortunately, around 3,000 inhabitants were displaced and the 
village  San Francisco over the Rosario River, disappeared due the long period of 
political unrest, making no feasible additional studies (27), (5) .  
The coordinator of malaria control program verified from a list the village with current 
evidence of autochthones cases reported. In each village the community was invited to 
participate and after writing consent the sampling was conducted. Sampling by 
convenience was done, and participants located in each information post with help of 
local leaders. Protocols of security for humanitarian mission were activated according to 
particular conditions. From each volunteer a capillary blood sample was taken one for a 
thick blood smear, and for Rapid Diagnose Test, RDT, manufactured by Standard 
Diagnostic Inc. Asymptomatic cases were defined as any person without 
symptomatology compatible to malaria, but showing a positive RDT. Fever was defined 
as any patient with more than or equal to 38,0 Celsius degrees according to WHO 
Guidelines. Treatment of malaria episodes:  individuals with malaria infections di were 
treated according to malaria guidelines of the National Control program in 
Colombia(28), (29). In Latin America a case of malaria is defined as all patient with or 
without symptomatology and positive presence of parasites. The descriptive statistics 
and association were estimated using Stata 13. The level of significance was at 5%. 
4.4 Ethical considerations 
The study was undertaken according to the basic principles of the Helsinki declaration 
and Resolution 8430 of the Ministry of Health of Colombia, October 4th ,1993.The study 
was cleared by the Ethical Committee, of the Faculty of Medicine at the Universidad 
Nacional de Colombia, Bogota. In addition, informed consent was obtained from all 
study participants. For volunteers under 18 years old, the parents or legal guardian 
authorized participation, as per Articles 23 and 24 of Resolution 8430, 1993. According 
to national norms, the investigation was classified as a minimal risk study, as per Article 
11.
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4.5 Results 
A total of 528 subjects were sampled. Table 1 shows the prevalence of positive cases, 
defined as infected with or without symptomatology.  
Table 1. Socio-demographic characteristics of the sampled population 
Municipality and 
Population 
Population 
Sampled 
Malaria 
Prevalence 
RDT Positive 
% 
Main 
Occupation/Situation 
of Community 
Members 
TumacoUrban (102,495) 117 0 Agriculture 
Tumaco Rural (87,000) 112 0,9 Fishing 
Bocas de Satinga, Olaya 
Herrera (27,359) 
235 1,7 Fishing 
Puerto Libertador (47,643) 51 5,9 Displaced, miners 
Montelibano (81,351) 13 30.8 Displaced, 
subsistence 
farmers 
The four sampled villages experienced intense political unrest and had a high proportion 
of displaced populations, mainly in Cordoba Rural areas. According to CODHES, 
Colombia recorded five million displaced people by 2013(30).  From field observations 
the self medication was confirmed. The consumption of herbal infusions to reduce fever 
is very common in all areas, but in Tumaco, people prepare infusions of Cinchona Bark 
while all drug stores close to the temporary field station sold the tonic,“Arquin”, each 100 
ml containing 0.566g of chloroquine. Given the limited diagnostic services in the area 
and the cost of transport to a well-equipped health center, most people with fever or 
malaria-compatible symptomatology take theseavailable products. 
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Table 2. Malaria case distribution by municipality and species 
Code Age Sex Village Municipality Department To Diagnose RDT Occupation 
5 29 F Tierraadentro Monte Libano Cordoba 36,1 Mixed Housewife 
20 5 M Tierraadentro Monte Libano Cordoba 36,6 Vivax Infant 
28 27 M Displaced Monte Libano Cordoba 36,6 Mixed Unemployed 
47 40 F Terminal Puerto Libertador Cordoba 36,7 Vivax Housewife 
7 50 F Tierraadentro Monte Libano Cordoba 36,8 Vivax Housewife 
10 2 F Tierraadentro Monte Libano Cordoba 36,8 Mixed Housewife 
301 30 F Porvenir Tumaco Nariño 37,0 Falciparum Bingo 
52 23 M Juan Jose Puerto Libertador Cordoba 37,0 Vivax Army 
64 63 M Juan Jose Puerto Libertador Cordoba 37,1 Mixed Farmer 
2064 42 F Displaced Olaya Herrera Nariño 37,3 Mixed Housewife 
2173 33 F Satinga Olaya Herrera Nariño 37,4 Falciparum Housewife 
2037 20 F Santinga Olaya Herrera Nariño 37,5 Mixed Housewife 
2232 51 M Satinga Olaya Herrera Nariño 37,8 Falciparum Farmer 
2017 15 M Bellavista Olaya Herrera Nariño 37,8 Mixed Student 
19 6 M Tierraadentro Monte Libano Cordoba 38,7 Vivax Infant 
2030 37 M Satinga Olaya Herrera Nariño 38,7 Mixed Fisher 
55 19 M Juan Jose Monte Libano Cordoba 39,2 Vivax Farmer 
Table 2 shows the demographic and clinical characterization of thedetectedmalaria 
cases. Prevalence did not differ by sex or occupation. The findings suggest that P. vivax 
and mixed infections are a key public health problem in those areas. The age 
distribution of cases kept the historical epidemiology for these areas. The ages affected 
by the infection and disease  are grouped between 15-45 yrs. However, 70% of infected 
subjects were asymptomatic and the proportion of fever attributable to malaria was 42%. 
San Francisco Village study: Historical comparison 1995 
This Village was located on Tumaco rural area, over the Rosario River. A total of 1,685 
thick blood smears were taken. 41 (2.4%) patients reported fever, i.e. 
temperature >38C, and 151 (8.9%) tested positive for 
parasitesmicroscopically(6.2%P.falciparum and 2.3% P. vivax).  The totalproportionof 
positive cases in febrile episodes was 86%(19/22)and 8.7% (132/1,512) in afebrile 
subjects. The crude odds ratio of the association fever/parasitemia was 9.9 (95% 
confidence intervals, CI, 5.2%-18.7%, p-value< 0.0001). After adjusting forage and sex, 
the OR was 10.8 (95% CI 5.6-20.8, p-value< 0.0001).The crude proportion of fever 
attributable to malaria (PAF) was a 41.7%(95% CI 31.3%-  55.3%) and  42% (95% CI, 
38.1- 44.1, p- value<0.001) after adjusting forage and sex(31). 
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On this particular survey fever due by malaria  increasedwith the level of parasite 
density and,consequently, the frequency of fever associate to malaria decreases with 
age(31).After adjusting for age and sex, the odds of fever was 12.1 times higher among 
individuals exposed to Plasmodium vivax malaria parasites compared to those who 
were not exposed.  Although, a high association was also observed among those 
exposed to Plasmodium falciparum malaria, OR=11.4, it was slightly lower.  However, 
the proportion of fever attributable to Plasmodium falciparum was 33.2% higher than the 
fraction of fever attributable to Plasmodium vivax, where the proportion of fever 
attributable to malaria was =16.4%(31).  
During the last 20 years , there is a slightly reduction of asymptomatic and the PAF. The 
population of San Franciscowas in the middle of all actors in the armed conflict, and 
population was forced displace. Additional surveys are not possible, however the other 
regions sampled keep similar epidemiological conditions and same socio-economic 
factors which affect both Tumaco and the Pacific coast endemic areas. 
Table 3 presents most relevant aspects of the malaria control program of the eight 
countries on the same Amazon Region where Colombia also share similar eco-
epidemiological conditions. These findings suggest limited actions of surveillance and 
budget constraint. The case detection in some areas combine intensified active case 
detection. The activities are responsibility of the public sector, the review do not find the 
private health sector participation in most of the countries. The surveillance system in 
Colombia and other countries present data from years before 2013, there is not 
available data for more recent years. The surveillance system is not opportune and 
sensible in case detection. It is widely suggest levels of under report around 35% (15) 
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Table 3. Results of the Qualitative Review of Malaria Pre-elimination and elimination: 
Study case of countries on the Amazon Region. (32-42) 
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Strategies 
Country 
Promotion and 
Prevention 
Early detection 
Outbreak 
prediction 
Vector Borne 
Control 
Health System 
Strengthening,  
Planning, 
surveillance, 
operative research 
Peru Active, Passive and 
Intensive case detection 
_ACD;PCD;ICD 
Impregnated bed nets. 
Insecticides spraying , 
Control of swamps 
Surveillance irregular, 
Studies to establish 
insecticide susceptibility 
and research strategies 
is limited 
Colombia Passive Case Detection 
Combined treatment is 
free in public health 
sector 
Only few groups 
conduct active case 
detection 
Distribution of bed nets 
to all age groups 
Irregular Indoor residual 
spray 
Some communities 
reject impregnated bed 
net due to bad smell 
and allergic in children 
International 
partnerships with Global 
Fund, Swiss TPH, 
PAHO 
NIH-USA 
Public health and 
academic sector with 
limited access to 
financial support 
Bolivia Combine treatment is 
free, artemisinin 
treatment partially 
effective 
Programs of distribution 
of impregnated bed nets 
Indoor residual spray 
Responsibility of actions 
mainly in public health 
sector 
Ecuador PCD, combined 
treatment is free by 
public health sector 
There is not evidence in 
the  efficacy of indoor 
residual spray 
Free distribution of 
impregnated bed nets 
Combined therapy is 
distributed by public 
health sector free 
Venezuela PCD, ACD, 
Case detection by 
volunteers 
Diagnose by microscopy 
Residual spray Information capture is by 
hand and does not allow 
analyses to policy 
making decision 
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Guyana PCD Massive bed net 
distribution, residual 
indoor spray limited 
results 
Limited evidence and 
resources for operative 
research 
Surinam ACD, PCD, Intense 
Case Detection 
Indoor spray residual,  
Impregnated bednets, 
Protection to pregnant 
women 
Educational campaigns 
and promote of 
Behavioral changes 
Brazil ACD, PCD, ICD Indoor and outdoor 
residual spray, 
Impregnated Bed nets, 
swamp elimination 
Limited Sentinel 
surveillance of 
insecticide vector 
susceptibility 
Limited evidence of 
interventions efficacy 
4.6 Discussion 
The findings show that P. vivaxmalaria is still endemic in Cordoba, while P. falciparum 
continues to be the main problem in Tumaco. However, the frequency and distribution of 
P. vivax and mixed infections indicate a weak effectiveness of malaria treatment in 
terms of prescriptions, delayed access and limited supervision by health actors.As other 
authors refer, Plasmodium vivax represents de 80% of  clinical malaria cases in Latin 
America and the Caribbean Island, meanwhile Plasmodium falciparum remains as a 
main cause of mortality 6 deaths per 100.000 inhabitants (32, 43) 
Policies and strategies formoving from malaria control to elimination require adequate 
planning to account for transmission levels and for the structure of health and social 
systems. Identification of asymptomatic and imported cases are key elements for 
malaria control planning. Assessing surveillance capacity and selecting relevant 
indicators for surveillance and monitoring are key preparatory issues that help to 
understand how the health and social systems function in a given place. In addition, 
countries must work in redefine and unified clinical malarial guidelines and protocols for 
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malaria transfusion at both rural and urban areas. It is important establish algorithms 
and diagnose criteria between semi immune population and immune populations from 
non-endemic and endemic regions. The impact and cost of malaria treatments due to 
inadequate management and implementation could be reduced by additional research 
to identify state of drug resistance and permanent sentinel surveillance systems(44), 
(45). 
The monitoring and evaluation of strategies of malaria elimination must be permanent. 
Definition of indicators for program managers at administrative level as well as lab and 
clinics places would contribute to forecast outbreaks and epidemics. The early detection 
of clinical failures in treatments will reduce the cost of changing treatments. 
In Latin America, has recorded contrasting evidence about the association of malaria 
and fever as a main symptom(17, 23). In similar regions, authors present contradictory 
results about the prevalence of asymptomatic infections, ranging from 4.2% to 96% (18), 
(19), (21), (22),(46). In Colombia, two studies conducted in Choco and Cordoba showed 
similar trends to those mentioned above. The study in Quibdo, highly endemic for 
P.falciparum, showed the absence of asymptomatic cases 
amongschoolchildren(47).Meanwhile in Tierralta, an area endemic for P.vivax,the study 
found 14.6%of cases were asymptomatic (23). These findings coincide with our 
results,showing exposure differences by sex and age, as well as the different 
symptomatic behavior patterns of the two species P.falciparum and P.vivax..Therefore, 
the differences in age and sex between the febrile and afebrilecases cannot be just a 
chance finding and merits further exploration.  
Despite these findings, the precision of estimates presented inthis studysuffers from the 
low number of cases and from the limited access to populations and population groups 
in the conflict zones. These results are consistent withprevious findings from other 
authors on the same region(48), (11), (49).  However, it must be noted that the 
proportion of fever attributable to malaria appears stable at around 39-42%. The degree 
of self-medication in some areas remains an important and big challenge to national 
efforts towards developing effective national surveillance systemsand to the National 
Institute for Food and Drug Surveillance(INVIMA). 
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The findings of this study have implications for malaria surveillance systems and malaria 
control and elimination programs .Currently, a malaria case is defined as any case that 
tests positive for parasites by thick blood smear and/or RDT. Presently, clinical cases 
are detected by passive case detection (PCD).  Active case detection has been reduced 
due to costs, such as those associated with transport to endemic areas. In Colombia, 
the priorities are: (i) to develop strategies for surveillance-response systems adapted to 
a given endemic area and (ii) to develop new strategies for primary and secondary 
preventive actions that also include different actors of the conflict, as well as active 
participation of the displaced Afro-Colombian and indigenous populations. Some of the 
cases detected came from those in the military; Colombia faces the task of reforming 
strategies in a way that allows young people to reflect more on their future and roles in 
society.  
The systematic narrative study and fieldwork show how the evidence between countries 
varies. There is not enough temporal and spatial information to indicate the real status 
of malaria elimination and pre elimination efforts in Latin America, mainly in the Amazon 
region. Any attempts to discuss progress towards malaria elimination will first have to 
elucidate and define parameters for statistically significant comparisons. Mathematical 
models offer a way to predict the value of progress indicators, while related informatics 
systems can help to evaluate the impact of elimination and control efforts considering 
variables of place, time and person. Tracking these epidemiological markers from 
infection o illness, plus setting a new threshold of fever, must be evaluated in both the 
short- and long-term to really have an impact on the malaria elimination strategy and 
redefine new programs. Finally, a sentinel surveillance system to measure and establish 
the state of native cases versus imported is also required between countries. The 
weekly report must be mandatory to forecast epidemics and prevent early presence of 
imported cases and avoid the malaria reintroduction in areas with Reproductive Rate 
close to Zero. 
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5.1 Resumen 
Introducción: En la actualidad el bocio endémico es considerado uno de los desórdenes 
producidos por la deficiencia de yodo. Su prevalencia en distintas regiones a nivel mundial, llevó a 
que algunos países declararan que estos desórdenes constituyen un problema de salud pública, no 
solo por las consecuencias directas en la salud de grupos vulnerables como las mujeres 
embarazadas y los niños en edad escolar sino por su impacto negativo en el desarrollo de las 
comunidades afectadas. En Colombia, se adoptó la yodización universal de la sal como principal 
estrategia para el control de estos desórdenes declarándose su eliminación a finales del siglo 
pasado. Objetivo: establecer la evidencia sobre el estado de las políticas y la prevalencia de bocio 
endémico y el estado nutricional del yodo medido por la determinación de la yoduria en algunas 
regiones del país. Metodología: realizar una revisión histórica de la literatura científica para 
Colombia y el estado de la eliminación de una patología que fue considerada endémica como es el 
Bocio. Uso de meta buscadores de la Universidad Nacional de Colombia. Conclusiones: Se 
requiere atención por parte de las autoridades sanitarias no solo por la persistencia de los 
desórdenes por deficiencia de yodo sino por el riesgo de enfermedades tiroideas por la ingesta 
excesiva de yodoen algunas regiones del país. Actualmente no hay política por que el país fue 
declarado libre de Bocio en 1990. Es necesario la organización del Sistema de Salud y la Política 
de Control Enfermedad Tiroidea. 
Palabras clave:Deficiencia de Yodo; Bocio endémico; Política de Salud; Glándula Tiroides; 
Colombia; Prevalencia (Fuente BIREME) 
5.2 Abstract 
Introduction: Goiter Syndrome is currently considered one of the iodine deficiency disorders 
(thyroids diseases). The prevalence of this  made it  some countries to declare this disorders as a 
public health problem, not just because of its direct health consequences on vulnerable groups like 
pregnant women and scholar children but its negative impact on the develop of the affected 
communities. Objective: To establish in Colombia, impact of the universal salt iodization adopted 
as the main strategy to control these disorders, and the state of declaration of  its elimination at the 
end of the past century. Methods: Narrative review of the scientific publication. Conclusions: Some 
subsequent reports had shown that goiter prevalence and iodine nutritional state measured by 
urinary iodine in some regions of the country requires the attention of the sanitary authorities not 
just for the persistence of this iodine deficiency disorders but also for the risk of thyroid diseases 
caused by excessive intake of iodine in some regions of the country.  Exist and urgent need to 
include again the sanitary policy and surveillance the thyroid diseases. 
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Keywords: Iodine Deficiency; Goiter; Endemic; Health Policy; Thyroid Gland; Colombia; 
Prevalence (Fuente BIREME, MeSH) 
Revisión de políticas sanitarias y situación actual del Bocio Endémico: El caso de Colombia 
5.3 Introducción 
Los desórdenes por deficiencia de yodo(1) son un conjunto de entidades patológicas que reflejan 
un estado de disfunción tiroidea ocasionado principalmente por el aporte insuficiente de yodo a la 
dieta. Aunque el entendimiento sobre su fisiopatología ha sido un gran avance para la medicina en 
el diseño de programas destinados al aumento del aporte de yodo a las poblaciones, en la 
actualidad estos desórdenes son un problema de salud pública en 54 países del mundo y se 
considera que a nivel global225 millones de escolares tienen una ingesta insuficiente de yodo 
(2).Respecto a esto,  Colombia implementó la política de yodización universal de la sal (YUS) y fue 
declarada en 1998 libre de los DDY. Sin embargo, se ha observado que algunos de los países que 
previamente habían alcanzado este logro han venido presentando prevalencias de bocio endémico 
y cifras de yoduria en escolares que demuestran que no se ha sostenido esta eliminación (3). Por 
esta razón, la tendencia mundial está dirigida al reconocimiento que los programas de control y 
eliminación de estos desordenes deben contar con al menos dos características fundamentales 
que les permitan lograr y sostener los resultados, la primera es el establecimiento de alianzas 
eficaces entre el sector sanitario, el académico y el industrial en la que se asegure el cumplimiento 
de los estándares establecidos en los procesos de yodización de la sal y la segunda es el uso 
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reflexivo de indicadores de impacto y sostenibilidad cuya finalidad radica en el seguimiento del 
estado nutricional del yodo en la población.    
5.4 Breve historia del Bocio Endémico 
El bocio endémico parece haber acompañado a la humanidad desde siglos pasados. Existen 
documentos que muestran que en la cultura china, en el siglo XXIX a. C ya se conocían distintas 
clases de tumores de cuello. Estos tumores también aparecen registrados en documentos Egipcios 
e Hindúes del siglo XVI a.C.En el siglo XVIII a.C., en el “Tratado sobre aguas y tierras” se asoció la 
presencia de bocio con el agua de ciertas regiones geográficas montañosas. Esta misma 
observación aparece en Roma entre los siglos I a.C. y I d.C.  así como la descripción de lo que 
parece concordar con lo que hoy conocemos como cretinismo “existen aguas que tienen el poder 
no solo de cambiar el cuerpo sino también la mente” (4). En América, antes de la conquista, 
algunos autores mencionan el uso del términocoto o ccotto  por los nativos (5)mientras que otros 
opinan que en la región no había bocio hasta el siglo XVIII y XIX(6). 
Aunque en el siglo XVI las características geográficas propias de las regiones con presencia de 
bocio que incluían regiones montañosas, llanuras aluviales a altura considerable y distantes del 
mar, con el correr de los años, estas características dejaron de ser relativamente exclusivas y se 
encontró que había deficiencia “significativa de yodo” en áreas costeras, ciudades y países 
desarrollados(3). 
En cuanto a la historia del tratamiento de esta patología, en China en los años 400-500 d.C 
algunos médicos chinos utilizaron Sargassum  y Laminaria Japonica   e incluso glándulas tiroides 
animales. Sin embargo, en los siglos previos existe evidencia de que los egipcios practicaban 
tratamiento quirúrgico a este tipo de tumores. Estas prácticas permanecieron aún hasta el siglo 
XV(7). David Marine se considera uno de los pioneros en la profilaxis masiva del bocio endémico 
“el bocio simple es la enfermedad prevenible más sencillaE debe ser excluida de la lista de 
enfermedades humanas tan pronto como la sociedad determine hacer el esfuerzo”  (8). 
En 1950, durante la Tercera Asamblea Mundial de la Salud se recomendó a los países que 
estudiaran la magnitud del bocio endémico en sus territorios y en 1958 la Organización Mundial de 
la Salud(9) publicó un conjunto de seis revisiones que pretendían aportar un enfoque a los 
trabajadores de salud pública de los países para el abordaje de la enfermedad.  
En 1960 la OMS reconocióque el esfuerzo por prevenir el bocio endémico todavía no había  sido 
hecho debido a que las autoridades sanitarias no estaban convencidas desu  inclusión dentro de 
los problemas de salud pública, de la eficiencia  y seguridad de las medidas profilácticas y de la 
factibilidad de superación de las dificultades técnicas de las intervenciones(7). 
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5.5 DEFINICIÓN DE LOS DESORDENES POR DEFICIENCIA DE YODO 
El único papel confirmado del yodo en el cuerpo humano es aquel relacionado con la síntesis de 
hormonas tiroideas (10).Los DDY son definidos por la Organización Mundial de la Salud (9)como 
las consecuencias de la deficiencia de yodo en una población que podrían ser prevenidas si esta 
tuviera una adecuada ingesta de yodo(3). Se considera como un “fenómeno ecológico natural”  en 
ciertas regiones del mundo, en las que existe pérdida de yodo del suelo debido a  erosión, perdida 
de vegetación y labores de pastoreo excesivas. 
En el cuadro 1 se muestran las dosis de yodo recomendadas en la dieta por la UNICEF, el ICCIDD 
y la OMS, que varían de acuerdo a la edad y estado fisiológico. 
Cuadro 1. Requerimientos de yodo en la dieta recomendados actualmente 
Rango de edad Dosis recomendada 
Niños preescolares (0-59 meses) 90 µg 
Niños escolares (6-12 años) 120 µg 
Adolescentes y adultos 150 µg 
Mujeres embarazadas y lactando 250 µg 
Fuente:(3). Adaptada por los autores. 
Los DDYson considerados una amenaza a la salud pública en países en los cuales la mediana del 
yodo urinario es menor a 100µg/L (2),  pues afecta especialmente la salud de los niños 
preescolares y de las mujeres embarazadas y el desarrollo de las poblaciones(2)(10).El espectro 
de DDY abarca el desarrollo de bocio, hipotiroidismo, anomalías congénitas, mortalidad perinatal e 
infantil, cretinismo, hipertiroidismo inducido por yodo, entre otros. Debido a la incorporación de 
yodo y la producción de hormonas tiroideas en el feto en formación el periodo más crítico abarca 
desde el segundo trimestre de embarazo hasta el tercer añoposterior al nacimiento(3). 
Actualmente se considera que la deficiencia de yodo es la causa prevenible más importante de 
daño cerebral  (3)y el principal motivo detrás de los programas de eliminación de los DDY(10). La 
deficiencia de yodo también tiene un impacto grave a nivel colectivo pues produce  alteración en el 
desarrollo físico y mental de las poblaciones con distintos grados de severidad, de modo que se ha 
reportado que las personas que viven en áreas afectadas por deficiencia severa de yodo pueden 
tener un coeficiente de inteligencia de 13.5 puntos menos que grupos control (11). 
5.5.1 Factores que influyen en la aparición de bocio 
El principal factor responsable de la deficiencia de yodo en el mundo es la baja ingesta de yodo en 
la dieta (10). Aparte de la deficiencia de yodo en la aparición de bocio endémico existen algunos 
factores etiológicos como los alimentos (mandioca, maíz, batatas, brotes de bambú, nabos, coles, 
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casaba,leches (Finlandia y Tasmania), ajo, cebolla, etc. La acción antitiroidea de los bociógenos se 
relaciona con la presencia de tiocianatos que inhiben el transporte del yoduro  y a altas dosis 
compiten con el yoduro en la síntesis de hormonas tiroideas. El potencial de desarrollo de bocio 
(“goitrogenicity” en inglés) está determinado por el balance entre los aportes de yodo y de 
tiocianatos cuando la razón yoduria (µg): tiocianato (mg) cae por debajo de 3” (10).Otros factores 
incluyen alteraciones nutricionales, factores genéticos, minerales presentes en fuentes hídricas 
(dureza del agua, concentraciones elevadas de calcio, magnesio y flúor y disminuidas de selenio y 
zinc), contaminación de las aguas de consumo humano y animal, presencia elevada de yoduros 
naturales en los ecosistemas de algunas regiones del mundo (Isla de Hokkaido en Japón y en la 
región de Salt Lake City), origen geológico de los suelos (12). 
5.6 SITUACIÓN DE LOS DDY EN EL MUNDO YPOLITCAS SANITARIAS ACTUALES  
En el año 1990, en la Cumbre Mundial para los Niños de las Naciones Unidas se reconoció la 
deficiencia de yodo como un problema de salud pública por lo que en 1991 se adoptó la meta de 
su eliminación en la Asamblea Mundial de la Salud y fue reafirmada en 1992 en la Conferencia 
Internacional de Nutrición. En 1993 la OMS y la UNICEF recomendaron como principal medida 
para el logro de esta meta la “yodización universal de la sal”.En el 2005 la Asamblea Mundial de la 
Salud adoptó el compromiso de reportar la situación global de los desórdenes por deficiencia de 
yodo cada tres años(3). 
En 1993 la OMS reportó el estado mundial de los desordenes por deficiencia de yodo basándose 
en la prevalencia de bocio endémico en los países. Posteriormente, ya que muchos países habían 
iniciado programas de eliminación de los DDY, la OMS volvió a analizar el estado nutricional de 
estos países mediante la medición de la yoduria y la prevalencia de bocio endémico con el fin de 
comparar los resultados de la década pasada.  Para esto recogió los datos de estudios nacionales 
y subnacionales realizados en distintos países del mundo entre 1993 y 2003 y evaluó la 
prevalencia total de bocio y la mediana del yodo urinario. Estos resultados se publicaron en el año 
2005(2)y mostraron que la deficiencia de yodo era considerada aún un problema de salud publica 
en 54 países del mundo y el 36.5% de los escolares del mundo (285 millones) pertenecían al grupo 
de ingesta insuficiente de yodo, al extrapolar este resultado a la población general se estima que 
cerca de dos billones de individuos tienen una ingesta insuficiente de yodo. En cuanto a la 
proporción de escolares con un estado nutricional deficiente de yodo este porcentaje varío entre un 
10.1% en la Región de las Américas y un 59.9% en la Región Europea.  En el Sureste Asiático el 
porcentaje fue de 39.9% y en el Pacifico Occidental de 26.2%. Con relación a la prevalencia total 
de bocio (PTB) en la población general, se estima que en el mundo la prevalencia es del 15.8%, 
variando entre un 4.7% para las Américas y un 28.3% en África y en comparación con los datos del 
año 1993,  la PTB aumento en un 31.7% a nivel global, a excepción de las Américas y el Pacifico 
Occidental en donde se presentó un descenso en la PTB en un 46% y 32.2% respectivamente. Sin 
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embargo, la TPB encontrada no es consistente con el estado nutricional del yodo actual, que se 
puede explicar por el retardo en los cambios en la TPB con relación al momento de 
implementación de la yodización de la sal. También se encontró que el número de países en los 
que la deficiencia de yodo representa un problema de salud publica disminuyó de 110 en 1993 
(medida por la PTB) a 54 (medida por el yodo urinario), en 43 países la nutrición con yodo es 
optima, en 54 es inadecuada y en 29 países la ingesta de yodo es más que adecuada o excesiva. 
Asimismo, estos hallazgos por regiones se correlacionan con el hecho de que las Américas sea la 
región en la que hay una mayor proporción de  hogares que consumen sal yodada (90%) en 
comparación con Europa que alcanza solo el 27%. 
5.6.1 La yodación de la sal como principal herramienta 
En la actualidad se reconocen diversas fuentes de aporte de yodo al ser humano, por ejemplo, en 
las zonas que no son endémicas de bocio se encuentran concentraciones de yodo en el agua de 
5µg/L y en las endémicas de 1µg/L. El aporte de yodo en el agua es de 10µg/L. En el aire  la 
presencia de yodo se relaciona con la contaminación atmosférica, en una región contaminada la 
atmosfera contiene hasta 1µg/m3 de yodo para un aporte diario de 10 a 20µg/día (12).  Sin 
embargo, la yodización de la sal es actualmente la estrategia más usada para el control y la 
eliminación de los DDY. La yodización universal de la sal es definida por la OMS  como la 
yodización de la sal para consumo humano y animal por encima de unos niveles fijados 
internacionalmente (>90% de los hogares)  (3). Además de la cobertura de este tipo de sal a la 
población afectada, la OMS llama la atención sobre la necesidad de vigilar la calidad del proceso 
de yodización y distribución de la misma, lo que requiere la colaboración de los sectores públicos y 
privados. Aparte de la yodización de la sal existen casos en los que es necesario el aporte de 
suplementos de yodo a las mujeres embarazadas y niños menores de 2 años  (13). 
5.6.2 Necesidad de seguimiento a los programas (Cuadro 2)  
Al existir distintos estados nutricionales de yodo en los países del mundo, la OMS ha reconocido 
que es necesario fortalecer el seguimiento a las políticas de yodización de la sal para asegurar que 
estas tienen el impacto deseado, así como para “identificar poblaciones en riesgo y asegurar una 
prevención y control sostenible de los desordenes por deficiencia de yodo” (2). Esto también 
debido a que la ingesta excesiva de yodo puede producir hipertiroidismo y enfermedades tiroideas 
autoinmunes (14). 
Hasta los años 90 la prevalencia total de bocio era utilizada como el principal indicador de la 
deficiencia de yodo en las poblaciones sin embargo lleva muchos años el cambio en la prevalencia 
de bocio una vez instauradas las medidas de yodización. La OMS recomienda el estudio en niños 
preescolares por su fácil acceso y porque son una representación adecuada del estado nutricional 
de la población general, sin embargo para monitorizar el impacto de los programas de yodización 
de la sal deben incluir a otros grupos vulnerables incluyendo a las mujeres embarazadas (2).  
Cuadro 2. Consecuencias en la salud por deficiencia y exceso en la ingesta de yodo. 
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Grupos etarios Deficiencia de yodo Exceso de yodo 
Todas las edades Bocio 
Hipotiroidismo 
Aumento  en la susceptibilidad de la 
glándula tiroides a la radiación 
nuclear 
Hipertiroidismo 
Tiroiditis autoinmune 
Feto Abortos 
Anomalías congénitas 
Aumento en la mortalidad perinatal 
Neonatos Cretinismo endémico 
Aumento en la mortalidad infantil 
Niñez y 
adolescencia 
Alteraciones en la función mental 
Retraso en el desarrollo físico 
Hipertiroidismo inducido por yodo 
Adultez Alteraciones en la función mental 
Hipertiroidismo inducido por yodo 
Disminución en la fertilidad 
Bocio inducido por yodo 
Fuente: (3) y (10) Adaptado por los autores. 
Para ello se han ideado distintas formas de seguimiento a los programas de yodización de la sal, 
de su impacto en la prevalencia de bocio endémico y otros desordenes por deficiencia de yodo y 
de su sostenibilidad una vez implementados los programas.  En los cuadros 3-5 se enumeran los 
criterios epidemiológicos para evaluar el estado nutricional de los escolares, por medio de la 
mediana de la yoduria, así como la clasificación clínica del bocio recomendada actualmente por la 
OMS  y la interpretación sobre su prevalencia para un territorio dado.  
5.6.3 Indicadores del proceso de yodización de la sal: 
La legislación apropiada y las regulaciones que apoyen los procesos son las piedras angulares de 
los programas de yodización de sal en los países. Una de estas regulaciones es aquella que 
especifica el contenido de yodo en la sal de consumo humano y animal en los sitios de producción. 
La OMS actualmente recomienda el método de titulación o sus equivalentes, asimismo se 
recomienda el uso de yodato de potasio en preferencia al yoduro por ser su mayor estabilidad 
(3).Dentro de los factores que determinan el contenido de yodo en la sal al nivel del consumidor se 
encuentran: 
Diferencias en la cantidad de yodo agregado a la sal, contenido diferente de yodo en un mismo lote 
o por bolsas de sal debido a fallas en el proceso de mezcla, falta de control de la humedad a lo
largo del proceso de producción (con pérdidas de yodo aproximadas entre el 30 y el 80%), perdida 
de yodo debido a impurezas de la sal, o por los procesos de lavado o cocción a nivel domiciliario, 
y disponibilidad de fuentes de sal no yodadas para el consumidor (3). Estos escenarios de perdida 
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potencial del contenido requerido de yodo en la sal indican la importancia de la evaluación de los 
procesos desde la producción, el empaquetamiento y distribución de la sal hasta el nivel del 
consumidor final.  
La OMS, UNICEF y el ICCIDD recomiendan que “considerando que bajo las condiciones habituales 
existe una pérdida del 20% del contenido de yodo desde el productor hasta el consumidor, otro 
20% en los procesos de cocción previas al consumo, que en promedio  una persona ingiere 10g de 
sal al día, se recomienda un contenido de yodo en la sal en el sitio de producción de 20-40 mg de 
yodo  por kg de sal (20-40 ppm) para proveer 150 µg de yodo al día.  Para las comidas procesadas 
se debe utilizar sal con un contenido de yodo cercano al rango inferior recomendado (3). 
Sin embargo además del monitoreo del contenido de yodo en la sal es necesario determinar la 
yoduria en  muestras representativas a nivel nacional, siendo el rango recomendado de 100-199 
µg/L en la población general y 150-249 µg/L en las mujeres embarazadas (3).. A partir de los 
resultados de la población, la OMS recomienda considerar los determinantes del consumo de 
yodo, como son: 
- El porcentaje de casas que utilizan sal adecuadamente yodada. 
- Calidad en el sitio y procesos de producción, empaquetamiento, distribución. 
- Hábitos alimentarios con relación al consumo y uso de la sal. 
5.6.4 Indicadores de impacto: 
El yodo urinario se prefiere como indicador de impacto de los programas de control de los DDY 
porque refleja la ingesta actual de yodo y responde relativamente rápido a la corrección de la 
deficiencia(10). La OMS recomienda que los estudios de deficiencia de yodo se hagan en 
escolares entre 6-12 años de edad(2).  A pesar del desfase en los cambios de la PTB y el estado 
nutricional del yodo, la PTB es considerada un indicador práctico de evaluación de base en áreas 
donde la deficiencia de yodo es severa(2).   
Cuadro 3. Criterios Epidemiológicos para evaluar el estado nutricional del yodo en escolares 
(mayores a 6 años) y en mujeres embarazadas por medio de la concentración urinaria de yodo. 
Grupo poblacional Yoduria 
(µg/L)* 
Ingesta de yodo Estado del yodo 
Niños escolares >6 
años. 
<20 Insuficiente Deficiencia de yodo severa 
20-49 Insuficiente Deficiencia de yodo moderada 
50-99 Insuficiente Deficiencia de yodo leve 
100-199 Adecuada Nutrición adecuada de yodo 
200-299 Por encima de los 
requerimientos 
Es posible que provea una 
adecuada ingesta a las mujeres 
embarazadas o lactando, pero 
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representa un posible riesgo 
para la población general†. 
≥300 Excesiva Riesgo de consecuencias 
adversas para la salud ‡ 
Mujeres 
embarazadas 
<150 Insuficiente 
150-249 Adecuada 
250-499 Por encima de los 
requerimientos 
≥500 Excesiva 
Mujeres lactando y 
niños < 2 años. 
100 Adecuada 
Fuente: (3)y(10)(2)Adaptado por los autores. 
*Como la distribución del yodo urinario no es normal, el punto de corte es definido en la base de
valores de mediana(10).  
† Riesgo de hipertiroidismo inducido por yodo posterior a la introducción de yodización de la sal  en 
grupos susceptibles(2). 
‡ Hipertiroidismo inducido por yodo, tiroiditis autoinmune 
Cuadro 4. Clasificación simplificada del bocio por palpación 
Grado 0 Bocio no palpable ni visible 
Grado 1 Bocio palpable pero no visible cuando el cuello está en posición normal, 
incluyendo nódulos tiroideos en una tiroides no aumentada de tamaño. 
Grado 2 Bocio claramente visible cuando el cuello está en posición normal, consistente con 
un aumento del tamaño de la tiroides a la palpación.  
Fuente: (3)Adaptado por los autores. 
Cuadro 5. Severidad de los DDY según criterios epidemiológicos 
Grado de los DDY, expresados como porcentaje del total de escolares 
evaluados 
Total goitrerate 
Prevalencia de 
bocio 
Ninguno Leve Moderado Severo 
0.0-4.9% 5.0-19.9% 20.0-29.9% ≥30% 
Fuente: (3)  y (10)Adaptado por los autores. 
5.7 EL CASO DE COLOMBIA. HISTORIA DE LAS POLITICAS SANITARIASY SITUACION DE 
LOS DDY EN COLOMBIA 
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En Colombia entre los siglos XVI y XVIII cronistas como Fray Pedro Aguado reportaron la 
prevalencia de bocio en distintas regiones.Francisco José de Caldas también registro la 
enfermedad que se presentaba “a lo largo del Rio Magdalena hastala confluencia del Rio Cauca” 
(15). En 1832 el francés Boussingault recomendó el consumo de sal  procedente de fuentes 
yodadas para la prevención del coto en Colombia y en 1857 el Congreso de la República convocó 
a los científicos de la época para que investigaran en la prevención y tratamiento del bocio. Sin 
embargo, solo hasta la primera mitad del siglo pasado se conoció la magnitud y gravedad del 
problema del bocio endémico en Colombia gracias a laEncuesta Nacional de Bocio, realizada entre 
1945 a 1948. Esta encuesta estudió 183.243 escolares de ambos sexos, correspondientes a 385 
municipios del país. Esta encuesta mostró una prevalencia de bocio de 52,6 %, siendo los 
Departamentos más afectados los de Caldas, Cauca, Huila, Tolima y Boyacá. 
En 1947 se aprobó la Ley 44 por medio de la cual se creó el antiguo Instituto Nacional de Nutrición, 
como dependencia del Ministerio de Higiene, y se determinó la yodación de la sal. 
En 1950 la Concesión de Salinas del Banco de la República inició la producción de 300 toneladas 
mensuales de sal yodadacon 50 ppm de yodo. Gran parte de esta sal se distribuyó en siete 
municipios del Departamento de Caldas que previamente habían sido seleccionados debido a que 
su prevalencia superaba ampliamente el promedio nacional. A los dos años el Instituto Nacional de 
Nutrición realizó una nueva encuesta en los escolares de estos municipios para determinar la 
efectividad de las medidas de yodación de la sal en la prevención del bocio endémico. Esta nueva 
encuesta mostró una reducción acentuada en la prevalencia del bocio endémico general para los 
siete municipios de 83,1% a 33,9%”  (15). 
El Decreto Legislativo 0591 de 1955 estableció la yodación de la sal para consumo humano y 
animal, de acuerdo con las normas de la OMS (50-100 ppm de yodo) y en 1959 la Concesión de 
Salinas construyó una refinería moderna para este fin(15). En 1959 el Ministerio de Salud Pública 
“encarga al Instituto Nacional de Nutrición  de efectuar el control y la supervisión de la yodación de 
la sal” en el país y tres años después mediante la Ley 14 y el Decreto Reglamentario 1908 se 
establece que la Concesión  Salinas transfiera a esta entidad 2 centavos por cada libra de sal 
yodada en Colombia   (12). 
En 1960 la Encuesta de Nutrición de Colombia encontró que la prevalencia debocio endémico era 
de  41% en los niños menores de 15 años. En Colombia, la explotación de las salinas marítimas y 
terrestres fue contratada por el Gobierno con el Banco de Ia República desde 1931 bajo la 
Concesión de Salinas. Para 1965 se explotaban las salinas terrestres de Zipaquirá en el  interior 
del país y las marítimas de Manaure y Galerazamba sobre el Mar Caribe”(15). 
En 1959 la yodación cubrió el 48 % de la sal producida en el país; en 1964 este porcentaje subió al 
76 %, y en 1966 se calcula que el 55 % de la sal producida en Colombia se encontraba yodada. El 
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15% restante corresponde a sal marina, utilizada en su mayoría para consumo animal y uso 
industrial.“El control efectivo de la yodación de la sal en Colombia se inició en 1963, después de la 
creación del nuevo Instituto Nacional de Nutrición”(15). 
Para la evaluación de estas medidas a escala nacional se realizaron encuestas nacionales en 
escolares, una de ellas se limitó a los siete municipios del Departamento de Caldas mientras que 
otra se diseñó en dos etapas: la primera de ellas limitada a los Departamentos que habían 
presentado una prevalencia de bocio mayor del 50% en la encuesta nacional (Boyacá, Caldas, 
Cauca, Huila, Tolima y Valle).En 1968 la Ley 75 responsabiliza al Instituto Colombiano de 
Bienestar Familiar del control de la yodación de la sal y se aumenta en cinco centavos el aporte por 
libra de sal yodada vendida.Luego la Ley 27 de 1974 establece la participación del ICBF en el 12% 
del precio oficial de la sal (12). 
Al finalizar la década de los años 70, la Ley 09 de 1979 determina “que la sal para consumo 
humano se considere un alimento” (12)y en los años posteriores se dictan decretos reglamentarios 
de esta Ley que establecen entre otras el control del reempaque de la sal yodada. Durante el 
periodo 1947 – 1983 las muestras analizadas de sal yodada en el país no solo eran menores al 
número mínimo analizable por ley sino que no cumplían con los requisitos mínimos de contenido 
de yodo establecido por la OMS. Para este periodo, Carrillo muestra que de las 9000 muestras 
analizables mínimas por ley esperadas, solo se analizó un numero de 2462, de las cuales 429 
tenían un contenido de yodo entre 50-100 ppm, 1967 tenían menos de 50 ppm y 66 tenían mas de 
100 ppm para un promedio del contenido de yodo de 14.2 ppm (12).En 1992 el Decreto 6568 “crea 
el Comité Interinstitucional para la vigilancia de los desordenes por deficiencia de yodo, flúor y el 
control de la calidad de la sal para el consumo humano” (12). En 1998 el 91% de la sal para 
consumo humano estaba correctamente yodada y la prevalencia de bocio en escolares era del 7% 
por lo que el país fue declarado libre de Desórdenes por Deficiencia de Yodo.Entre1994 y 1996 se 
realizó un estudio de prevalencia de DDY Instituto Nacional de Salud en 74 municipios de 32 
departamentos. Este estudio mostró una prevalencia de bocio del 7 % en una muestra de 15 807 
escolares y una deficiencia de yodo en cerca de 6000 muestras de yoduria. Sobre esa base, los 
expertos de la Organización Panamericana de la Salud, UNICEF e ICCDDI que visitaron a 
Colombia recomendaron mejorar la organización y vigilancia, para asegurar sostenibilidad del 
programa(14). 
ESTUDIOS EN COLOMBIA (Cuadro 2)
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Cuadro 6. Estudios encontrados en la literatura sobre la prevalencia del bocio endémico en Colombia y políticas sanitarias de yodación para cada periodo* 
Periodo de 
estudio 
Política Nacional Tipo de Estudio 
Métodos de 
medición 
Área geográfica Muestra Prevalencia del BE Observaciones Fuente 
1942 153.000 
personas para el 
servicio militar 
10% (16) 
1945-1948 Ley 44 de 1944 
para Yodación 
de la sal. 
Transversal. 
Encuesta 
Nacional de 
Bocio 
Presencia de 
bocio clínico 
385 municipios 
en 14 
departamentos. 
183.243 
escolares a nivel 
nacional.  
52.62% (96.435 
casos) 
En 8.062 
escolares de 7 
municipios de 
Caldas 
prevalencia del 
83.1% de bocio 
(17) 
1952 Tranversal. 
Encuesta. 
Presencia de 
bocio clínico 
7 municipios de 
Caldas 
6.511 escolares 33.9% Reducción del 
83.1%  al 33.9% 
posterior al 
suministro de sal 
yodada. 
(18) 
1960 Decreto 
Legislativo 591 
de 1955 
1963 Control 
efectivo de la 
yodación 
Transversal. 
Encuesta de 
Nutrición de 
Colombia 
Presencia de 
bocio clínico 
por criterios 
de la OMS. 
Menores de 15 
años 
41% 
1965 Presencia de 
bocio clínico 
por criterios 
combinados 
uno es de la 
OMS. 
7 municipios de 
Caldas 
2166 escolares 1.8% y 0.8% según 
clasificación 
antigua y nueva 
respectivamente.  
(19) 
1978 (20) 
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1994-1996 74 municipios 
de 32 
Departamentos 
15.807 
escolares, 5971 
muestras de 
yoduria 
7% bocio 
endémico,  92.8% 
Deficiencia de 
yodo. 
(21) 
2006-2007 Descriptivo 
transversal. 
Yoduria 
(método 
Sandell-
Kolthkoff 
modificado) 
Quindío (6 
municipios) 
444 escolares 
(8-18 años)  
28.8% Déficit de 
yodo (11.5% déficit 
severo, 12.6% 
déficit moderado, 
4.7% déficit leve). 
59.3% Ingesta 
excesiva de yodo. 
Diferencia 
significativa de 
deficiencia entre 
los estratos, 
procedencia rural 
o urbana y
municipio. 
(14) 
* Posterior a la política de yodización universal de la sal en el país y de acuerdo con los parámetros recomendados por la OMS para el seguimiento de los
programas(3), al comparar la prevalencia de bocio endémico en cada periodo debe considerarse que solo representa una proporción de los DDY y que en la 
actualidad su presencia no refleja con exactitud el estado de ingesta de yodo de la población general.  
84
5.8 DISCUSIÓN SOBRE EL SEGUIMIENTO EN COLOMBIA 
En el cuadro 7 se muestra los indicadores recomendados por la OMS para la evaluación en los 
países con programas de control y eliminación de los DDY, las entidades en Colombia 
encargadas de estas mediciones y las observaciones de los autores sobre la situación del país 
respecto a cada uno de ellos. 
Cuadro 7.Indicadores utilizados en los programas de control de los DDY*. 
Tipo de 
Indicador 
Objetivo 
Medidas 
empleadas 
Sectores 
Responsables 
Observaciones 
Indicadores de 
proceso 
Monitoreo y 
evaluación de 
los procesos de 
yodización de sal 
Contenido de 
yodo en sal en 
procesos de 
producción, 
importación, en 
hogares y en la 
industria 
alimenticia. 
INVIMA 
Indicadores de 
impacto 
Evaluación del 
estado del yodo 
en la población y 
el impacto de los 
programas de 
yodización de la 
sal.  
La principal es la 
mediana de yodo 
urinario. 
Determinación 
de bocio por 
palpación o 
ultrasonido. TSH 
en neonatos y 
tiroglobulina en 
escolares como 
indicadores de 
función tiroidea.  
INS, ICBF Una vez 
implementada la 
yodización de sal 
los cambios en la 
prevalencia de 
bocio no reflejan 
con exactitud el 
estado de 
ingesta de yodo 
de la población.  
Indicadores de 
sostenibilidad 
Evaluación de la 
eliminación de 
los DDY y de la 
sostenibilidad de 
los programas. 
Mediana de yodo 
urinario en la 
población (100-
199ug/L) y en 
mujeres 
embarazadas 
(150-249 ug/L) 
Disponibilidad de 
sal yodada en los 
hogares (>90%) y 
logro de 8 de 10 
indicadores 
programáticos. 
INS Ultimo estudio 
disponible de 
yoduria es del 
2007. Plan 
Estratégico 
Nacional 2007-
2010. 
*Abreviaturas utilizadas en la tabla: DDY Desórdenes por deficiencia de yodo.
Fuente: (3)Adaptado por los autores. 
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La eliminación de los DDY se logra cuando la yodización de la sal puede ser sostenida. Esto 
implica que una vez que se logra este reconocimiento los países deben asegurarse del 
mantenimiento de estos logros mediante un sistema adecuado de monitoreo y evaluación que 
parta desde un nivel regional y nacional (3).La importancia de alcanzar la eliminación de estos 
desórdenes radica en su afectación a las poblaciones de distintos grupos de edad, con un alto 
impacto en el desarrollo infantil, no solo en cuanto a la presencia de formas severas de 
alteraciones cognitivas sino en el desarrollo de formas leves que alcanzan mayor distribución. 
Por lo anterior, el seguimiento activo a estos programas no solo es beneficioso para las 
poblaciones desde el punto de vista de salud pública sino que trasciende al impacto de  estas 
medidas en el desarrollo económico de las mismas (3). Esto es importante si se tiene que la 
falta de sostenimiento de las medidas de control y vigilancia ha llevado a un retroceso en áreas 
que previamente habían logrado la eliminación. En Colombia, Gallego y cols. en un estudio 
reciente en la población de Quindío sugieren que la presencia de DDY podría estar ligada a las 
políticas de seguridad alimentaria (14). Asimismo, las condiciones propias de las distintas áreas 
rurales o urbanas y de los estratos socioeconómicos con relación a las fuentes de acceso a 
alimentos asociados a la  presencia de desnutrición en estas poblaciones se reflejan también 
en que existan áreas donde el problema no sea la deficiencia sino el exceso de yodo.  
Aunque el presente estudio no cuenta aun con datos y aportes de las entidades encargadas 
oficialmente del monitoreo del programa de eliminacion de los DDY en su fase de seguimiento 
y sostenibilidad, los resultados preliminares de la revisión indican por lo menos tres 
conclusiones preliminares de la situación del bocio endémico en el país y sus políticas 
sanitarias: 
1. No se conoce con exactitud datos reales sobre la carga de los DDY en el país, ni su
distribución por regiones, estratos socioeconómicos, y grupos poblacionales. 
2. Falta información sobre los indicadores del proceso de yodización de la sal periódicos y
accesibles a la comunidad académica. 
3. Sin los datos anteriores no se puede establecer la efectividad de los programas actuales, la
situación real del bocio y de otros DDY en el país así como tampoco su comportamiento en 
respuesta a las medidas de control implementadas.  
Debido a lo anterior, consideramos necesario el establecimiento de encuestas regionales con 
muestras significativas, de escolares, mujeres embarazadas y otros grupos poblacionales cuyo 
objetivo sea la determinación de la situación nutricional de yodo de los individuos, la 
prevalencia de bocio endémico y la carga de los DDY en el país. En la actualidad el uso de 
software especializados permiten el diseño de mapas que ayuden en la identificación de 
prioridades en salud pública y orienten en la planeación de programas y posterior seguimiento. 
Asimismo, consideramos que esta información requiere ser relacionada con los estudios de 
contenido y estabilidad del yodo en la sal en los distintos niveles de proceso de producción así 
como la investigación de los determinantes culturales y socioeconómicos que influyen en el 
acceso y consumo de la sal en las distintas regiones del país. Consideramos que este análisis 
podrá ser útil a las autoridades sanitarias en la evaluación de la yodización de la sal, su 
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impacto real en la salud de la población y la investigación en otras estrategias que permitan 
aportar este micronutriente a  los grupos con requerimientos especiales. 
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CHAPTER VI. GENERAL DISCUSSSION and RECOMMENDATIONS 
This thesis explores the challenges and opportunities for controlling and eliminating diseases of 
poverty and neglected tropical diseases (NTDs)(1), using malaria as a case study and focusing on 
the Latin American context, yet drawing out generalizable lessons for all endemic areas. Diseases 
of poverty and NTDs continue to be a major public health burden in tropical areas, especially in 
resources constrained countries. Some disease areas, like smallpox, have surpassed the goal of 
elimination to achieve eradication while others, like goiter, have rolled back to a state of re-
emergence in some developing countries (2), (3), (4),(5, 6), (7), (8). Impact indicators at both local 
and global levels can be affected by population and microorganism dynamics. In addition, health 
systems and stakeholders cannot forecast uncertainties such as natural disasters, outbreaks, 
epidemics and sudden budget constraints. These are among the structural determinants and 
barriers to completing the process of elimination and eradication, from a public policy and planning 
perspective.  
In this chapter, we discuss possible limitations of the study and draw some mid-level conclusions 
that may allow for public health action as well as process of planning in health services. 
This study was conducted in a representative sample of people affected by malaria and other 
infectious diseases of poverty. Given the magnitude of the population at risk, additional studies 
must be conducted in order to stablish the goals achieved in terms of the direct relation investment 
and malaria indicators of elimination. However, the variables included in the analyses represent 
common risk factors for endemic areas in Colombia. The Caribbean and Pacific coastal regions 
account for around 70% of all malaria cases in the country. Agriculture and mining are the core 
economic activities in these two natural regions. The population in these regions are 
disproportionately affected by conditions of poverty, political unrest, and the presence of illegal 
economies —all known determinants of malaria persistence and resurgence (9, 10).  When these 
factors are compared to those in other endemic countries, the similarity is considerable. For 
instance, colonization of the Brazilian Amazon region can explain the persistent conditions of 
poverty and the prevalence of endemic and epidemic infectious diseases like malaria and 
tuberculosis in the Amazon region. The “garimpeiros” — the migrants that went to the region to 
exploit its natural resources for short periods — dominated the region. The intense migratory 
movement of people without immunity, in and out of a malaria endemic region, created the 
epidemiological conditions for maintaining malaria transmission, in our case of study, however the 
health indicators such as maternal and infant mortality are not in better conditions. Malaria 
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situations are related to social, economic and cultural determinants and the trend of the disease is 
strongly associated to them. These basic characterization allow to extrapolate from our findings and 
make generalizations for areas with similar eco epidemiological conditions. Thus, the pilot model of 
pre-elimination or elimination developed in Colombia can be adapted and implemented in other 
endemic areas of the Amazon region. In fact, the RAVREDA group has been working along those 
lines, unfortunately with limited results up to now. There is an urgent need to compile and organize 
all the evidence on the elimination experience so far in order to make further informed decisions.  
Unfortunately, collaborative projects between national and regional health authorities tend to 
exclude the academic and private sectors. The problem is exacerbated by limited funding for 
developing field research and by the minimal interest in amalgamating actors and research 
evidence (11-13). 
The information provided by national and local health authorities were often incomplete or 
unavailable due to laws protecting personal data (habeas data) and other issues of confidentiality. 
The literature review shows that statistics on and reports of malaria interventions in Colombia and 
Latin America were not very well updated in libraries or on the web pages of various health 
institutions. In most cases, when a report refers to a particular year, the figures correspond to data 
collected two or three years before. The International Health authority in charge of compiling 
information for Colombia, both WHO and PAHO did not provide the original information. And the 
differences from WHO-RBM reports and local secondary information are not correlated.  
6.1. From elimination to equity and community empowerment 
This study comprised qualitative and quantitative investigation, fieldwork, systematic literature 
reviews and special surveys. Thus, the findings are based on triangulation of information from three 
kinds of sources, which show that there are enormous differences between endemic and non-
endemic areas in terms of health coverage, education indicators and development models. More 
specifically, rural and urban populations differ, not only in epidemiological and demographic aspects 
but also as regards equity, gender and ethnic considerations. Tracing the historic development of 
micro and macro structures in these endemic regions permits an understanding of how the towns, 
villages, and populations improved welfare. Those societal structures, from individual to community 
level that are well organised and permit entitlements and active participation in democracy, coincide 
with communities that have overcome the public health challenges associated with diseases of 
poverty. On the contrary, groups with low levels of empowerment maintain high rates of infant and 
maternal deaths and experience most of the burden of infectious diseases (14), (15-17) 
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The effort to control and hence reduce the impact and cost of infectious diseases has been a high 
priority since the mid-1950s(18), (19). Well-known challenges have been encountered, not only in 
setting an international agenda but also in transforming the health and education sectors. When 
reviewing the history from the inception of tropical medicine in 1951 to the more recent concept of 
international and global health, it becomes clear that improved sanitary conditions and better living 
conditions contributed to reducing mortality  as well as the burden of infectious diseases (20). 
The historical transformation of disease concepts is closely related to epidemiological and 
demographic transitions, and to transformations of structures and control policies. Public health 
programs have succeeded in reducing transmissible diseases in some endemic regions with 
historical evidence of outbreaks and epidemics. Control, elimination or the complete eradication of 
infectious diseases such as smallpox (21, 22)are evidence of the nature and impact of country 
successes. Currently, the global agenda promotes the strengthening of health systems as well as 
well-built control programs with adequately trained human resources and high level technology to 
improve action towards elimination and eradication of diseases in poor areas of the world. 
The design and implementation of this study considered many factors, including migration, access 
to health services, natural disasters, political unrest, poverty, and illegal economies. The main 
challenges, however, come from the limited efforts by networks and researchers in consolidating 
findings and making this information available not only to other partners but also to civil society and 
political decision makers. In Colombia and other countries in the region, public policies and plans of 
actions are poorly articulated, with absent processes for monitoring and evaluation between 
different sectors.  
The first conclusion of the investigation is the urgent need to recognize the other players and actors 
within the same society, as well as the innovate effective harmonization strategies among different 
levels of organization to ensure that results generated through research and/or public health actions 
are available and accessible. This in turn will allow any citizen to exercise her/his rights to be 
informed and make decisions according to information resulting from different scenarios into the 
system. Communities will not been powered or be able to participate designing health and 
education plans if access to information is limited. In that sense, Sen has referred to the freedom for 
development and entitlement and how greater participation and communication strengthen 
democracy. Martha Nussbaum complements the idea by discussing the relevance of participation of 
minorities and considering the social determinants of particular vulnerable groups(23), (24), (25, 
26). 
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The main challenges of validating and using results and evidence on experience/concepts of 
elimination of diseases of poverty in Colombia and Latin America was the limited capacity of the 
author to consolidate information from a wide range of sources with more holistic approaches. Here, 
the analyses are focused on how to collect the results of malaria control or elimination and 
comparing the trends in terms of improving or maintaining control policies. It also compares and 
establishes time-space relations and the experience of convergent and divergent trends in relation 
to elimination and control of common epidemiological patterns, taking into full consideration of a 
given the socio-cultural and socioecological situation and history of each  region(27), (28). The 
agencies responsible of elimination at the state and MoH, were reluctant to provide information 
which will to correlate investment, plans of action and  both mortality and morbidity of malaria.  
The secondary sources allow suggesting that Colombia and its neighbouring countries intend to 
make use of concerted efforts and inter-sectoral collaboration to eliminate and reduce to zero not 
only malaria, but also NTDs such as leprosy, American Trypanosomiasis, Leishmaniasis, dengue, 
goiter diseases, and infant mortality. Unfortunately, the presence of the new epidemics of Zika and 
chikungunya confirm that vector-borne programs and policies are not yet well articulated. For 
example, only the number of Zika cases, till 16 week 2016, is > 40,000 cases and we regularly face 
isolated outbreaks of dengue. Or, the malaria day, past 25th of April, Choco department had 
recorded 19’915 cases of malaria caused by Plasmodium falciparum, and 30 deaths 
(www.elcolombiano.com, www.defensoriadelpueblo.org; accessed 1st May 2016).   
During the last 20 years, Latin America has maintained similar epidemiological patterns, with 
diseases of poverty and NTDs remaining unstable and very difficult to control. Countries in and out 
of the Amazon region have been challenged by outbreaks of dengue, malaria, and recently by Zika 
and Chikungunya viruses(28), (29). Fortunately, most epidemiological alerts coincide with 
international tournaments. For instance, in 2007, Brazil celebrated the Pan Americans Games and 
faced the challenge of controlling a dengue epidemic. In 2015, Chile fought against a Chikungunya 
epidemic during the Americas Football Cup, and now the big challenge will be guaranteeing safety 
conditions due to the Zika epidemic affecting Brazil and Colombia, with the Olympic games 
scheduled to take place in Brazil in August 2016. Health authorities and sport players alike are 
concerned about the risk and sanitary conditions. The actions implemented are not permanent and 
structural. Instead, most of them are for a short period and limited in coverage. So it is quite 
probably that Latin America, will attend more epidemics and emerging diseases. 
These epidemiological markers and the magnitude of the affected population offer evidence to 
public health programs, States and society of the relevance of inter sectoral cooperation and of the 
urgent need to strength surveillance systems and weekly reporting. 
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6.2 General considerations on the elimination of NTDs 
Analyses of elimination programs in Latin America and the rest of the world are focused on malaria. 
Colombia maintains similar policies of control and indicators do not show considerable changes in 
favour of reduction of transmission. The agreements between countries’ health actors are mainly to 
support partnerships and accomplish the goals fixed by PAHO and WHO (30, 31), (32, 33). If tasks 
go well, the question will be how close programs and institutions are to keeping malaria incidence 
close or equal to zero and how sustainable are the results in the long term?  
With regards to NTDs, leprosy in Colombia is an interesting example. Leprosy is a very limited 
problem and affects no more than six municipalities (N=1.101). The annual incidence is very low, 
with 0.89 cases among 100,000 inhabitants, i.e. around 300 new cases each year (34). 
Unfortunately, the number of relapses is almost 12% and 30% of patients (3/10) are handicapped at 
level 2. Fixed dose multidrug regimens have been implemented since 1985 and led to major 
improvements. In 2005, there was a slight increase of the number of cases, most probably due to 
problems with the surveillance program. We are now at the point of needing more applied research 
projects to evaluate the state of drug resistance as well as the effectiveness of the surveillance 
system, including the level of community participation throughout the programme. The 
stigmatization and occupational incapacity are truly compelling reasons to aim for elimination, which 
will improve the quality of life and well-being of those most at risk. In addition, the failure to inform 
and educate the community or to include them in surveillance approaches have been revealed as 
key problems of the National Leprosy Elimination program (35, 36). Interestingly, in the same 
region, Brazil is the country that has still not achieved the elimination goal owing to a series of 
socio-cultural factors and inadequate information and surveillance approaches leading to early 
diagnosis and prompt treatment in the health system (37).  
Another example among the NTDs is the attempt to eliminate Chagas’disease. The scenario in the 
region shows substantial differences in control and elimination strategies within and between 
countries. Countries with rigid structures of planning and control at different levels present better 
results(38). Argentina has a Federal Plan of Health, Brazil has decreed a Social Invest Fund, Bolivia 
has the Chagas Law, however Uruguay is the country with the most commitment elimination and 
better results. Uruguay focused on eliminating the vector through structural household 
improvements in rural areas, serology to detect vertical transmission and rigorous  surveillance of 
all blood derivates in haematological centres(39).  The most successful strategies consider 
multilevel participation, integrated interventions targeting host, parasite, and vector, and better living 
conditions. The screening of pregnant women for Chagas’ disease is a priority only in Uruguay and 
Bolivia. In Colombia, vector control with insecticide spray exists, but young patients have limited 
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access to treatment. In areas with intense conflict, access to radical treatment is not possible and 
most patients do not complete treatment. 
These two examples are correlated with the results obtained almost 15 years after goiter disease 
elimination in Colombia. Sustainability of both control or elimination programs must be considered in 
the plans, which are implemented for ten years at a time without indicators for monitoring and 
evaluation. When designing programs, stakeholders and communities are strongly advised to 
include interim evaluations that consider not only impact indicators of diseases and mortality but 
also societal and economic risk factors, which clearly influence  final results and may even lead to 
other public health actions. 
Common determinants for these endemic diseases are poverty and the vulnerable conditions of 
children and pregnant women, who are the most affected but neglected populations in their state. 
Colombia was declared free of goiter disease by 1990. Our findings show clearly how for different 
conditions and diseases entities the same risk groups are identified (7).  The goiter problem is an 
example of a clearly multi factorial disease problem. Besides autoimmune factors, diet and 
consumption of iodized salt is also implicated. The reintroduction of this public health problem is 
explained by low and high ingestion of iodized salt. Unfortunately, the macro determinants are 
inadequate diets in children and pregnant women as a consequence of the globalization of nutrition 
conditions on the one hand, and the weak food and drug surveillance system to guarantee the 
quality of salt for human consumption on the other. The consequences of food globalization and 
resulting feeding habits are well known, including its effect on the new pandemic of type II diabetes 
plus obesity (40).  
The control or elimination of other infectious diseases related to poverty, like malaria, HIV/AIDS and 
TB, or NTDs, are governed mainly by social determinants. The low success rates of control and 
elimination efforts are strongly associated with low levels of community empowerment and high 
levels of inequity. In countries with better indicators of health and education, public health policy 
design often considers the local condition and encourages active participation of the population in 
solving the problem. Countries with a limited public policy impact often show both weak governance 
and  limited transparency in its processes. Colombia started decentralizing its health services 
in1986 (Law 12). However, given the low administrative levels of less developed municipalities it 
introduced Law 715 in2004 in order to exempt rural areas from the decentralization process, 
bringing these responsibilities once again to administrative departments in the capital, where the 
budget in different contexts leads to different outcomes compared to the real costs encountered / 
budgeted for a given subnational level. When analyses are conducted to compare the Internal 
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Gross Product, some countries like Mexico, Colombia and Bolivia show an improvement of their 
economies. This does not mean that communities, families and individuals receive better incomes 
or salaries. The illegal economies in the region have been reduced considerably due to legal 
actions and international partnerships but, unfortunately, the number of people of productive age 
employed in the informal sector has increased or remained stable(41, 42).  
Data from occupation risk databases show that only 6 million workers are formally linked to 
institutions. Equity indicators like the Ginni Coefficient in countries like Bolivia or Colombia do not 
reflect this social injustice. However, poverty conditions and misery remain stable in numbers. To 
achieve many of the goals proposed in the new agenda, the conditions of living, household, 
employment, social security affiliation and alleviation of climate change must be included in a 
decennial plan, with indicators of process, outcome and results. 
6.3 Elimination of malaria in Colombia: How far is it? 
Recent publications have analysed the distribution of malaria cases for endemic countries in Latin 
America(43), (44), (45). The distribution and frequency of the disease suggest some considerable 
changes in patterns of transmission. There is an agreement that malaria morbidity due to 
Plasmodium falciparum was considerably reduced and mortality attributed to this species is 
considerably low. However, the long series of data are not consistent with a real trend of reduced 
morbidity rates. There are considerable variations and peaks, which suggest instability within the 
programs and maybe also budget constraints to implementing sustainable programs towards 
elimination. The incidence and prevalence estimation could coincide at times with elimination 
(epidemiological periods close to zero), however sudden epidemics or deaths are still possible, 
which can be forecast and avoided with preventive actions from the public and private health 
sector(46), (47).In Colombia, the number of deaths associated with malaria is unclear. Some 
authors have referred to underreporting and low coverage of the surveillance system; hence the 
analyses of malaria trends under this scenario risks possible biases. The field study conducted in 
Tumaco, Montelibano, Puerto Libertador and Bocas de Satinga showed evidence of asymptomatic 
cases in urban areas, through active case detection (48). The surveillance system is the 
responsibility of the National Health Institute, SIVIGILA, but the stability of human resources and the 
capacity of health institutions to systematically capture and analyse field information is not assured 
and partly unknown. The municipalities, in most of cases, do not have computer equipment or 
secure access to big cities. For reasons mentioned above, a combination of factors contributes to 
the persistence of malaria and other infectious diseases.  
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Finally, sentinel surveillance to follow-up treatment failures, the development of resistance against 
anti-malarials, treatment adherence, self-medication and monitoring of vector insecticide resistance, 
is absent in endemic areas. 
Malaria is concentrated in municipalities and villages where more than 80% of the population has 
unmet basic needs. In these areas, the right to health for the population must be upheld by 
authorities.  They must guarantee access to water and food, and education and health. The infant 
mortality rates in Colombia vary widely. In the Andean region, rates are20/1000, while the Pacific 
Coast experiences rates similar to Africa of 80/ 1000. The first one shows a pattern of 
epidemiological and demographic transition, while regions like the Pacific, Caribbean, Amazon and 
Orinoquia have a pyramidal shaped population structure. African descendants and indigenous 
groups are the ethnic minorities.  The African descendants are mainly located on the Pacific Coast 
where malaria falciparum cases and other transmissible diseases are prevalent. Indigenous 
populations are mostly found in the Caribbean, Amazon and Orinoquia regions, where the P.vivax 
cases are more frequent and  hepatitis, tuberculosis and serious malnutrition form a great 
burden(14, 17, 49-51). 
Under these variations, evident through data analyses, with unstable trends, peaks of new cases in 
inter years and intrinsic and extrinsic factors affecting the dynamics of transmission and sources of 
information, it is quite difficult to assume that the programs are on their way to or are achieving 
elimination. Consequently, the basic determinants of malaria transmission persist as a common 
factor within and between the 21 Latin American countries reporting malaria cases.  
6.4. Recommendations for further research and public health action 
6.4.1 Further research to be undertaken: 
Field research conducted in two natural regions of Colombia, with eco-epidemiological conditions 
for vector borne disease transmission as well as the presence of socio-economic indicators of 
poverty, suggest that additional operational research is needed. During the elaboration of this 
thesis, several outbreaks and epidemics were reported. The frequency and distribution of malaria, 
dengue, Chikungunya and Zika, in areas under 2000 m above sea level, require characterization of 
the risk factors and of the main social, political, cultural and economic determinants associated with 
the persistence and re-emergence of these kinds of communicable diseases. The first question is a 
socio demographic one and requires establishing the degree of relational transmission vs. 
transmission due to migration and forced displacement. In a globalized world, where several 
regions and countries are used as a corridor to finding better options in life, Colombia is not an 
exception. Migrant populations from Africa, Asia and the Caribbean Islands, pass through Colombia 
96
and contribute to spreading diseases not only transmitted by direct contact but also by arthropods 
like Anopheles spp. and Aedes spp when people arrive infected from their place of origin. The 
policy of migration and the International Sanitary Code must be updated to reflect these new 
epidemiological conditions and to guarantee minimal risk for both the receiving population as well 
as the migrants themselves(9).  
Colombia and Latin America did not achieve the MDG related to alleviating climate change(52). 
Most of these pathologies, where a vector is involved, are strongly associated with extreme 
changes in temperatures and rain fall. The current evidence is not sufficient for evaluating the 
integration and adaption of vectors to higher levels above the sea. Future research should examine 
how these arthropods adapt to survive and subsequently change the patterns of transmission. 
Studies about vector genetics and patterns of adaptability to new ecosystems should be linked to 
studies on transmission capability and its impact on control measures and re orientation of 
programs. 
Few studies related to primary productive systems have been carried out (53), (54), (55) . There is a 
positive correlation between primary structures of society and malaria persistence and resurgence. 
The poverty and poor models of development associated with illegal economies and displacement 
are among the main determinants.  The difficulties of eliminating and eradicating infectious 
diseases from endemic regions in Colombia and Latin America can be traced back to those 
structures(48, 56, 57). 
Our field work identified barriers to accessing health services. First geographical barriers (distance) 
and the cost of transportation are important causes of late diagnosis and inadequate treatment. 
Thus, febrile patients usually consume herbal and bark infusions, i.e. cinchona bark . In addition, 
the living conditions —unprotected houses, without potable water— are another risk factor for 
malaria transmission (48, 58). Considerable resources have been invested in researching 
treatments and insecticides and many studies of RDT have been published. There is no evidence 
that eradication of any vectors is possible and/or feasible. What is the magnitude of the impact on 
malaria risk reduction when living conditions are improved? In Colombia and Latin America, 
financial resources are used only to support the biological model perspective and the triadic: 
mosquito, parasite, host. However, innovation based on biological, social and social science models 
are less frequent. If the number of cases has been reduced to the levels reported by health 
authorities, then why not re-orient part of the budget to improve the quality of houses and provide 
adequate latrines to reduce the impact on the environment? Studies, since 1900 have suggested 
the benefits of re-designing places for living (59). The explanation is simple: the purpose of the 
primary prevention is to reduce incidence. This decrease is given by the fact that risk factors and 
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host contact almost disappeared. The number of new cases starts to decline and the chain of 
transmission is blocked. The modification of domiciliary and peri-domiciliary characteristics could 
consider the participation of community and local authorities.  
Control, elimination, and eradication are arts and depend on the capability and articulation at all 
levels, from the individual, family, and community to actors in health systems and the State; all must 
work as an artificial open system, where the parts depend on the whole and vice versa. The system 
must be dynamic and modifiable depending on society’s needs. Furthermore, cause and effect is 
not direct, it works in both directions i.e. malaria eradication leads to better productive system and 
quality of life; better productive system and quality of life contributes to malaria eradication. 
6.4.2 Recommendation for public health action 
The information obtained in this study and the analyses conducted at different levels and correlated 
to other sources and findings allow some basic recommendations that can be implemented at three 
levels: health system and legal regulation, social justice and equity, and community and other 
sectoral participation. 
6.4.2.1. Health System and Legal Regulation 
a. The Ministry of Health at the legislative level is directly responsible for new health system reforms
and for designing action plans according to the structural organization of departmental and 
municipal health services. The redirection of responsibilities call on both public and private sector to 
strengthen strategies for active and passive case detection, and to focus on early diagnosis and 
prompt treatment. In rural and remotes areas, human resource and infrastructure must be a priority.  
b. The National Institute of Health at the executive level requires financing to innovate surveillance
systems, including forecasting of epidemics and outbreaks, sentinel surveillance of parasite drug 
resistance and vector insecticide resistance, as well as clinical studies in vivo, and adherence to 
treatment by infected patients. New techniques are also needed to detect self-medication. The 
INVIMA, Institute for food and drug surveillance, implement adequate control and supervision in 
rural areas regarding distribution and sale of antimalarial medications  
c. Primary Health Care programs require adaptation according to local needs in all institutions. In
addition, financial resources could be directed to diagnose the health situation and update clinical 
guidelines 
d. Health promotion and disease prevention in rural areas affected by malaria must be incorporated
at local health programs along with monitoring and evaluation indicators to reflect activity plans and 
budget. 
e. Academy and National Department of Investigation: organise and define priority areas of
research with budget assigned from state with transdisciplinary participation of research groups 
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d. Malaria research funding distributed on equity principles
6.4.2.2 Social Justice and Equity 
The main social determinants of malaria persistence that jeopardize elimination or reduction to zero 
in Colombia and countries in the Andean region, is poverty and inequities in access to health and 
education. 
a. Children and pregnant women need to be included in special programs of control,
Decennial Public Health Plan should include an specific chapter with actions and result
indicators
b. Programs for vulnerable minorities and populations from primary productive sectors in
endemic areas identified; priority health care attention to reducing geographical barriers and
other factors that delay diagnosis and adequate treatment; and education of patients for
treatment adhesion and not self-medication
c. Investment of resources to improve health infrastructure in rural areas
d. Reduce the inequities between rural and urban populations: primary productive sectors,
politics to alleviate climatic change and natural disaster
6.4.2.3 Community Education and Empowerment 
The structure of the society, and the active participation of its members is crucial. This calls for the 
development of community surveillance and control actions that the community itself can implement 
and thus will to contribute and complement to health authorities’ integrated control plans. 
a. Organise communities in groups according to roles in their community and levels of risk
b. Participation of educational sector is fundamental to training and teaching children who can
translate those experiences to their families, given that in these areas many parents are
illiterate
c. Colombia is a country with one of the highest rates of dysfunctional families. Due to the
war, mothers are in charge of children and also find formal or informal employees to
guarantee social security and incomes for the family. Mother and caregiver must be trained
and offer welfare conditions to contribute to infectious disease reduction; they and their
children must be visible to society and to the health and education sectors. A network of
community surveillance with a bonus could help to update information and forecast and
prevent outbreaks.
6.5 Do we need vaccines? 
The effective use of mass vaccination has shown to be useful in controlling infectious 
diseases. Polio and measles are only two examples of vaccine benefit for non-immune 
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populations. The implementation of a malaria vaccine requires some specific conditions: it 
must be low cost, require a maximum of 2 doses, and achieve efficacy around 90%. All the 
vaccines introduced into the Expanded Immunization Programme should guarantee full 
protection and also herd immunity. It is compulsory that the candidate vaccine 
demonstrate protective immune response and a wide range of coverage give the variety of 
strains. Finally, we all recognize that a vaccine will surely be a great achievement, but it is 
even greater to see a vaccine to become an effective complement of the already existing 
tools for control and elimination.  
On this century, health efforts are concentrated on vaccines, drugs and technology 
innovation. Only 10% of those technology and therapies for humans are being used.  The 
spray of resources for health effective interventions and the considerable number of 
agencies, NGOs, reflect the absent of policies and programs for International Health 
Authorities.  
Famines, increased number of refugees, climatic change, and epidemics are telling more 
than we can understand and suggest the need of a new  and re-structured global agenda: 
multilevel and inclusive.  
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